Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	(R)-limonene 6-monooxygenase activity	CYP2C19 CYP2C9	1.67e-05	2	82	2	GO:0052741
GeneOntologyMolecularFunction	(S)-limonene 6-monooxygenase activity	CYP2C19 CYP2C9	1.67e-05	2	82	2	GO:0018675
GeneOntologyMolecularFunction	(S)-limonene 7-monooxygenase activity	CYP2C19 CYP2C9	1.67e-05	2	82	2	GO:0018676
GeneOntologyMolecularFunction	limonene monooxygenase activity	CYP2C19 CYP2C9	1.67e-05	2	82	2	GO:0019113
GeneOntologyMolecularFunction	granulocyte colony-stimulating factor receptor binding	PSG2 PSG3 PSG11	2.35e-05	14	82	3	GO:0005130
GeneOntologyMolecularFunction	oxidoreductase activity, acting on CH or CH2 groups	CYP2C19 CYP2C9 XDH	2.93e-05	15	82	3	GO:0016725
GeneOntologyMolecularFunction	arachidonate 11,12-epoxygenase activity	CYP2C19 CYP2C9	9.94e-05	4	82	2	GO:0008405
GeneOntologyMolecularFunction	linoleic acid epoxygenase activity	CYP2C19 CYP2C9	9.94e-05	4	82	2	GO:0071614
GeneOntologyMolecularFunction	GPI anchor binding	PSG2 PSG3 PSG11	1.11e-04	23	82	3	GO:0034235
GeneOntologyMolecularFunction	fatty acid omega-1 hydroxylase activity	CYP2C19 CYP2C9	1.65e-04	5	82	2	GO:0120502
GeneOntologyMolecularFunction	long-chain fatty acid omega-1 hydroxylase activity	CYP2C19 CYP2C9	1.65e-04	5	82	2	GO:0120319
GeneOntologyMolecularFunction	arachidonate 14,15-epoxygenase activity	CYP2C19 CYP2C9	1.65e-04	5	82	2	GO:0008404
GeneOntologyMolecularFunction	lipid binding	IGF1 NF1 PSG2 PSG3 SFTPD PSG11 PCLO GAS6 OSBPL9 OSBPL11 SMO APOB TEC	1.84e-04	988	82	13	GO:0008289
GeneOntologyMolecularFunction	filamin binding	PSG2 PSG3 PSG11	2.26e-04	29	82	3	GO:0031005
GeneOntologyMolecularFunction	Toll-like receptor binding	PSG2 PSG3 PSG11	2.26e-04	29	82	3	GO:0035325
GeneOntologyMolecularFunction	bile acid transmembrane transporter activity	PSG2 PSG3 PSG11	3.64e-04	34	82	3	GO:0015125
GeneOntologyMolecularFunction	protein tyrosine kinase binding	PSG2 PSG3 PSG11 GAS6 TP53	3.72e-04	149	82	5	GO:1990782
GeneOntologyMolecularFunction	oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor	CYP2C19 CYP2C9	4.59e-04	8	82	2	GO:0033695
GeneOntologyMolecularFunction	caffeine oxidase activity	CYP2C19 CYP2C9	4.59e-04	8	82	2	GO:0034875
GeneOntologyMolecularFunction	cell adhesion molecule binding	FLNB IGF1 FN1 PTPRM NECTIN1 NECTIN2 CASR PLEC PHLDB2	7.74e-04	599	82	9	GO:0050839
GeneOntologyMolecularFunction	estrogen 16-alpha-hydroxylase activity	CYP2C19 CYP2C9	8.94e-04	11	82	2	GO:0101020
GeneOntologyMolecularFunction	glycolipid binding	PSG2 PSG3 PSG11	1.07e-03	49	82	3	GO:0051861
GeneOntologyMolecularFunction	retinoic acid 4-hydroxylase activity	CYP2C19 CYP2C9	1.47e-03	14	82	2	GO:0008401
GeneOntologyMolecularFunction	protein phosphatase binding	TRAF3 PSG2 PSG3 PSG11 TP53	1.74e-03	210	82	5	GO:0019903
GeneOntologyMolecularFunction	protein homodimerization activity	CDSN PSG2 PSG3 PSG11 NECTIN1 NECTIN2 RDH5 XDH CASR DGCR8	1.82e-03	815	82	10	GO:0042803
GeneOntologyMolecularFunction	phospholipid binding	NF1 PSG2 PSG3 PSG11 PCLO GAS6 APOB TEC	1.84e-03	548	82	8	GO:0005543
GeneOntologyMolecularFunction	steroid binding	IGF1 OSBPL9 OSBPL11 SMO	2.20e-03	133	82	4	GO:0005496
GeneOntologyMolecularFunction	organic hydroxy compound transmembrane transporter activity	PSG2 PSG3 PSG11	3.00e-03	70	82	3	GO:1901618
GeneOntologyMolecularFunction	sterol binding	OSBPL9 OSBPL11 SMO	3.12e-03	71	82	3	GO:0032934
GeneOntologyMolecularFunction	lipid transmembrane transporter activity	PSG2 PSG3 PSG11	3.38e-03	73	82	3	GO:0170055
GeneOntologyMolecularFunction	arachidonate epoxygenase activity	CYP2C19 CYP2C9	4.34e-03	24	82	2	GO:0008392
GeneOntologyMolecularFunction	phosphatase binding	TRAF3 PSG2 PSG3 PSG11 TP53	4.64e-03	264	82	5	GO:0019902
GeneOntologyBiologicalProcess	negative regulation of hepatocyte proliferation	PSG2 PSG3 PSG11 SMO	1.12e-06	20	83	4	GO:2000346
GeneOntologyBiologicalProcess	regulation of natural killer cell mediated cytotoxicity directed against tumor cell target	PSG2 PSG3 PSG11 NECTIN2	2.04e-06	23	83	4	GO:0002858
GeneOntologyBiologicalProcess	oligodendrocyte apoptotic process	IGF1 GAS6 TP53	2.17e-06	7	83	3	GO:0097252
GeneOntologyBiologicalProcess	regulation of natural killer cell mediated immune response to tumor cell	PSG2 PSG3 PSG11 NECTIN2	2.44e-06	24	83	4	GO:0002855
GeneOntologyBiologicalProcess	natural killer cell mediated cytotoxicity directed against tumor cell target	PSG2 PSG3 PSG11 NECTIN2	2.44e-06	24	83	4	GO:0002420
GeneOntologyBiologicalProcess	natural killer cell mediated immune response to tumor cell	PSG2 PSG3 PSG11 NECTIN2	2.89e-06	25	83	4	GO:0002423
GeneOntologyBiologicalProcess	wound healing	IGF1 NF1 FN1 PSG2 PSG3 PSG11 GAS6 PLEC TEC F9 PHLDB2	4.45e-06	493	83	11	GO:0042060
GeneOntologyBiologicalProcess	regulation of vasculogenesis	PSG2 PSG3 PSG11 XDH	5.36e-06	29	83	4	GO:2001212
GeneOntologyBiologicalProcess	negative regulation of interleukin-1 production	IGF1 PSG2 PSG3 PSG11 GAS6	1.06e-05	72	83	5	GO:0032692
GeneOntologyBiologicalProcess	negative regulation of oligodendrocyte apoptotic process	IGF1 GAS6	1.60e-05	2	83	2	GO:1900142
GeneOntologyBiologicalProcess	regulation of hepatocyte proliferation	PSG2 PSG3 PSG11 SMO	1.62e-05	38	83	4	GO:2000345
GeneOntologyBiologicalProcess	negative regulation of phosphate metabolic process	IGF1 NF1 PSG2 PSG3 INHA PSG11 XDH SMO PLEC TP53	2.18e-05	478	83	10	GO:0045936
GeneOntologyBiologicalProcess	negative regulation of brown fat cell proliferation	PSG2 PSG3 PSG11	2.22e-05	14	83	3	GO:0070348
GeneOntologyBiologicalProcess	negative regulation of phosphorus metabolic process	IGF1 NF1 PSG2 PSG3 INHA PSG11 XDH SMO PLEC TP53	2.26e-05	480	83	10	GO:0010563
GeneOntologyBiologicalProcess	negative regulation of myeloid leukocyte differentiation	NF1 PSG2 PSG3 INHA PSG11	2.38e-05	85	83	5	GO:0002762
GeneOntologyBiologicalProcess	regulation of brown fat cell proliferation	PSG2 PSG3 PSG11	2.76e-05	15	83	3	GO:0070347
GeneOntologyBiologicalProcess	positive regulation of homophilic cell adhesion	PSG2 PSG3 PSG11	2.76e-05	15	83	3	GO:1903387
GeneOntologyBiologicalProcess	negative regulation of natural killer cell mediated immune response to tumor cell	PSG2 PSG3 PSG11	2.76e-05	15	83	3	GO:0002856
GeneOntologyBiologicalProcess	negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target	PSG2 PSG3 PSG11	2.76e-05	15	83	3	GO:0002859
GeneOntologyBiologicalProcess	negative regulation of phosphorylation	IGF1 NF1 PSG2 PSG3 INHA PSG11 XDH SMO PLEC	3.35e-05	401	83	9	GO:0042326
GeneOntologyBiologicalProcess	insulin receptor internalization	PSG2 PSG3 PSG11	3.39e-05	16	83	3	GO:0038016
GeneOntologyBiologicalProcess	epithelial cell proliferation involved in liver morphogenesis	PSG2 PSG3 PSG11 SMO	3.50e-05	46	83	4	GO:0072575
GeneOntologyBiologicalProcess	hepatocyte proliferation	PSG2 PSG3 PSG11 SMO	3.50e-05	46	83	4	GO:0072574
GeneOntologyBiologicalProcess	negative regulation of epithelial cell proliferation	NF1 PTPRM PSG2 PSG3 PSG11 XDH SMO	3.54e-05	226	83	7	GO:0050680
GeneOntologyBiologicalProcess	brown fat cell proliferation	PSG2 PSG3 PSG11	4.10e-05	17	83	3	GO:0070342
GeneOntologyBiologicalProcess	insulin catabolic process	PSG2 PSG3 PSG11	4.10e-05	17	83	3	GO:1901143
GeneOntologyBiologicalProcess	keratinocyte development	FLNB CDSN PLEC	4.10e-05	17	83	3	GO:0003334
GeneOntologyBiologicalProcess	granulocyte colony-stimulating factor signaling pathway	PSG2 PSG3 PSG11	4.10e-05	17	83	3	GO:0038158
GeneOntologyBiologicalProcess	liver morphogenesis	PSG2 PSG3 PSG11 SMO	4.50e-05	49	83	4	GO:0072576
GeneOntologyBiologicalProcess	regulation of immune response to tumor cell	PSG2 PSG3 PSG11 NECTIN2	4.50e-05	49	83	4	GO:0002837
GeneOntologyBiologicalProcess	regulation of response to tumor cell	PSG2 PSG3 PSG11 NECTIN2	4.88e-05	50	83	4	GO:0002834
GeneOntologyBiologicalProcess	osteoclast differentiation	NF1 PSG2 PSG3 PSG11 TCIRG1 SBNO2	4.90e-05	162	83	6	GO:0030316
GeneOntologyBiologicalProcess	regulation of homophilic cell adhesion	PSG2 PSG3 PSG11	4.91e-05	18	83	3	GO:1903385
GeneOntologyBiologicalProcess	bone resorption	NF1 PSG2 PSG3 PSG11 TCIRG1	4.97e-05	99	83	5	GO:0045453
GeneOntologyBiologicalProcess	response to wounding	IGF1 NF1 FN1 PSG2 PSG3 PSG11 GAS6 PLEC TEC F9 PHLDB2	6.51e-05	659	83	11	GO:0009611
GeneOntologyBiologicalProcess	camera-type eye morphogenesis	BMP7 NF1 ALMS1 PTPRM NECTIN1 IRX6	6.62e-05	171	83	6	GO:0048593
GeneOntologyBiologicalProcess	negative regulation of cytokine production	IGF1 FN1 PSG2 PSG3 INHA SFTPD PSG11 GAS6 MAPKBP1	7.35e-05	444	83	9	GO:0001818
GeneOntologyBiologicalProcess	immune response to tumor cell	PSG2 PSG3 PSG11 NECTIN2	7.63e-05	56	83	4	GO:0002418
GeneOntologyBiologicalProcess	negative regulation of fat cell proliferation	PSG2 PSG3 PSG11	7.93e-05	21	83	3	GO:0070345
GeneOntologyBiologicalProcess	negative regulation of response to tumor cell	PSG2 PSG3 PSG11	7.93e-05	21	83	3	GO:0002835
GeneOntologyBiologicalProcess	negative regulation of immune response to tumor cell	PSG2 PSG3 PSG11	7.93e-05	21	83	3	GO:0002838
GeneOntologyBiologicalProcess	gland morphogenesis	BMP7 IGF1 PSG2 PSG3 PSG11 SMO	8.27e-05	178	83	6	GO:0022612
GeneOntologyBiologicalProcess	negative regulation of cell development	BMP7 IGF1 NF1 PSG2 PSG3 INHA PSG11 TP53	8.78e-05	353	83	8	GO:0010721
GeneOntologyBiologicalProcess	tissue remodeling	IGF1 NF1 PSG2 PSG3 PSG11 TCIRG1 TP53	8.99e-05	262	83	7	GO:0048771
GeneOntologyBiologicalProcess	negative regulation of granulocyte differentiation	PSG2 PSG3 PSG11	9.16e-05	22	83	3	GO:0030853
GeneOntologyBiologicalProcess	glial cell apoptotic process	IGF1 GAS6 TP53	9.16e-05	22	83	3	GO:0034349
GeneOntologyBiologicalProcess	negative regulation of osteoclast differentiation	NF1 PSG2 PSG3 PSG11	9.37e-05	59	83	4	GO:0045671
GeneOntologyBiologicalProcess	regulation of oligodendrocyte apoptotic process	IGF1 GAS6	9.55e-05	4	83	2	GO:1900141
GeneOntologyBiologicalProcess	negative regulation of platelet aggregation	PSG2 PSG3 PSG11	1.05e-04	23	83	3	GO:0090331
GeneOntologyBiologicalProcess	ameboidal-type cell migration	BMP7 IGF1 NF1 FN1 PTPRM PSG2 PSG3 PSG11 SMO PLEC	1.06e-04	577	83	10	GO:0001667
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	PTPRM PSG2 PSG3 PSG11 NECTIN1 NECTIN2	1.08e-04	187	83	6	GO:0007156
GeneOntologyBiologicalProcess	vasculogenesis	PSG2 PSG3 PSG11 XDH SMO	1.14e-04	118	83	5	GO:0001570
GeneOntologyBiologicalProcess	positive regulation of vasculogenesis	PSG2 PSG3 PSG11	1.20e-04	24	83	3	GO:2001214
GeneOntologyBiologicalProcess	vasculature development	BMP7 IGF1 LLGL2 NF1 FN1 PTPRM PSG2 PSG3 PSG11 LAMA4 XDH SMO APOB	1.25e-04	969	83	13	GO:0001944
GeneOntologyBiologicalProcess	negative regulation of protein phosphorylation	IGF1 NF1 PSG2 PSG3 PSG11 XDH SMO PLEC	1.33e-04	375	83	8	GO:0001933
GeneOntologyBiologicalProcess	common myeloid progenitor cell proliferation	PSG2 PSG3 PSG11	1.36e-04	25	83	3	GO:0035726
GeneOntologyBiologicalProcess	regulation of platelet activation	PSG2 PSG3 PSG11 TEC	1.45e-04	66	83	4	GO:0010543
GeneOntologyBiologicalProcess	phosphatidylinositol 3-kinase/protein kinase B signal transduction	IGF1 NF1 FN1 PSG2 PSG3 PSG11 GAS6 XDH	1.51e-04	382	83	8	GO:0043491
GeneOntologyBiologicalProcess	regulation of endothelial cell differentiation	PSG2 PSG3 PSG11 XDH	1.54e-04	67	83	4	GO:0045601
GeneOntologyBiologicalProcess	fusion of virus membrane with host plasma membrane	NECTIN2 GAS6	1.59e-04	5	83	2	GO:0019064
GeneOntologyBiologicalProcess	membrane fusion involved in viral entry into host cell	NECTIN2 GAS6	1.59e-04	5	83	2	GO:0039663
GeneOntologyBiologicalProcess	regulation of ERK1 and ERK2 cascade	IGF1 NF1 FN1 PSG2 PSG3 PSG11 GAS6 CASR	1.60e-04	385	83	8	GO:0070372
GeneOntologyBiologicalProcess	bone remodeling	NF1 PSG2 PSG3 PSG11 TCIRG1	1.62e-04	127	83	5	GO:0046849
GeneOntologyBiologicalProcess	regulation of tissue remodeling	NF1 PSG2 PSG3 PSG11 TP53	1.68e-04	128	83	5	GO:0034103
GeneOntologyBiologicalProcess	biomineral tissue development	BMP7 IGF1 NECTIN1 GAS6 TCIRG1 SBNO2	1.70e-04	203	83	6	GO:0031214
GeneOntologyBiologicalProcess	regulation of fat cell proliferation	PSG2 PSG3 PSG11	1.71e-04	27	83	3	GO:0070344
GeneOntologyBiologicalProcess	eye morphogenesis	BMP7 NF1 ALMS1 PTPRM NECTIN1 IRX6	1.74e-04	204	83	6	GO:0048592
GeneOntologyBiologicalProcess	circulatory system development	BMP7 IGF1 LLGL2 NF1 FN1 PTPRM PSG2 PSG3 PSG11 LAMA4 XDH SMO APOB PLEC MBD2 TP53	1.78e-04	1442	83	16	GO:0072359
GeneOntologyBiologicalProcess	regulation of bone resorption	NF1 PSG2 PSG3 PSG11	1.83e-04	70	83	4	GO:0045124
GeneOntologyBiologicalProcess	negative regulation of homotypic cell-cell adhesion	PSG2 PSG3 PSG11	1.91e-04	28	83	3	GO:0034111
GeneOntologyBiologicalProcess	regulation of vascular permeability	PSG2 PSG3 PSG11 PLEC	1.93e-04	71	83	4	GO:0043114
GeneOntologyBiologicalProcess	response to tumor cell	PSG2 PSG3 PSG11 NECTIN2	1.93e-04	71	83	4	GO:0002347
GeneOntologyBiologicalProcess	hindbrain development	BMP7 IGF1 SMO CLP1 TP53 SEZ6	1.94e-04	208	83	6	GO:0030902
GeneOntologyBiologicalProcess	negative regulation of myeloid cell differentiation	NF1 PSG2 PSG3 INHA PSG11	2.08e-04	134	83	5	GO:0045638
GeneOntologyBiologicalProcess	negative regulation of leukocyte proliferation	NF1 PSG2 PSG3 SFTPD PSG11	2.08e-04	134	83	5	GO:0070664
GeneOntologyBiologicalProcess	regulation of fibroblast proliferation	IGF1 NF1 FN1 GAS6 TP53	2.15e-04	135	83	5	GO:0048145
GeneOntologyBiologicalProcess	regulation of cell activation	IGF1 FN1 PSG2 PSG3 INHA SFTPD PSG11 NECTIN2 GAS6 SMO TEC	2.18e-04	756	83	11	GO:0050865
GeneOntologyBiologicalProcess	epithelium development	FLNB BMP7 CDSN IGF1 LLGL2 NF1 ALMS1 PSG2 PSG3 PSG11 XDH CASR SMO PLEC TP53 PHLDB2	2.19e-04	1469	83	16	GO:0060429
GeneOntologyBiologicalProcess	monoterpenoid metabolic process	CYP2C19 CYP2C9	2.37e-04	6	83	2	GO:0016098
GeneOntologyBiologicalProcess	regulation of epithelial cell differentiation	BMP7 PSG2 PSG3 PSG11 XDH SMO	2.43e-04	217	83	6	GO:0030856
GeneOntologyBiologicalProcess	anatomical structure formation involved in morphogenesis	BMP7 NF1 FN1 PTPRM PSG2 PSG3 PSG11 NECTIN1 NECTIN2 TCIRG1 SMO IRX6 PLEC TP53 PHLDB2 SBNO2	2.44e-04	1483	83	16	GO:0048646
GeneOntologyBiologicalProcess	regulation of natural killer cell mediated cytotoxicity	PSG2 PSG3 PSG11 NECTIN2	2.51e-04	76	83	4	GO:0042269
GeneOntologyBiologicalProcess	negative regulation of multicellular organismal process	BMP7 IGF1 NF1 FN1 ALMS1 PTPRM PSG2 PSG3 INHA SFTPD PSG11 GAS6 LAMA4 SMO MAPKBP1 TP53	2.54e-04	1488	83	16	GO:0051241
GeneOntologyBiologicalProcess	negative regulation of platelet activation	PSG2 PSG3 PSG11	2.60e-04	31	83	3	GO:0010544
GeneOntologyBiologicalProcess	myeloid leukocyte differentiation	NF1 PSG2 PSG3 INHA PSG11 TCIRG1 SBNO2	2.63e-04	312	83	7	GO:0002573
GeneOntologyBiologicalProcess	regulation of lipid metabolic process	IGF1 PSG2 PSG3 DNAJC19 DNAJC15 PSG11 APOB LACTB	2.65e-04	415	83	8	GO:0019216
GeneOntologyBiologicalProcess	ERK1 and ERK2 cascade	IGF1 NF1 FN1 PSG2 PSG3 PSG11 GAS6 CASR	2.78e-04	418	83	8	GO:0070371
GeneOntologyBiologicalProcess	negative regulation of bone resorption	PSG2 PSG3 PSG11	2.86e-04	32	83	3	GO:0045779
GeneOntologyBiologicalProcess	fat cell proliferation	PSG2 PSG3 PSG11	2.86e-04	32	83	3	GO:0070341
GeneOntologyBiologicalProcess	regulation of blood vessel remodeling	PSG2 PSG3 PSG11	2.86e-04	32	83	3	GO:0060312
GeneOntologyBiologicalProcess	regulation of natural killer cell mediated immunity	PSG2 PSG3 PSG11 NECTIN2	3.06e-04	80	83	4	GO:0002715
GeneOntologyBiologicalProcess	regulation of bone remodeling	NF1 PSG2 PSG3 PSG11	3.06e-04	80	83	4	GO:0046850
GeneOntologyBiologicalProcess	regulation of granulocyte differentiation	PSG2 PSG3 PSG11	3.14e-04	33	83	3	GO:0030852
GeneOntologyBiologicalProcess	negative regulation of feeding behavior	PSG2 PSG3 PSG11	3.14e-04	33	83	3	GO:2000252
GeneOntologyBiologicalProcess	blood vessel development	BMP7 LLGL2 NF1 FN1 PTPRM PSG2 PSG3 PSG11 LAMA4 XDH SMO APOB	3.30e-04	929	83	12	GO:0001568
GeneOntologyBiologicalProcess	negative regulation of vascular permeability	PSG2 PSG3 PSG11	3.44e-04	34	83	3	GO:0043116
GeneOntologyBiologicalProcess	negative regulation of bone remodeling	PSG2 PSG3 PSG11	3.44e-04	34	83	3	GO:0046851
GeneOntologyBiologicalProcess	negative regulation of lymphocyte mediated immunity	PSG2 PSG3 PSG11 C4BPA	3.52e-04	83	83	4	GO:0002707
GeneOntologyBiologicalProcess	regulation of phosphorylation	BMP7 IGF1 NF1 FN1 PSG2 PSG3 INHA PSG11 GAS6 XDH SMO PLEC DHX34 TP53	3.57e-04	1226	83	14	GO:0042325
GeneOntologyBiologicalProcess	negative regulation of leukocyte differentiation	NF1 PSG2 PSG3 INHA PSG11	3.61e-04	151	83	5	GO:1902106
GeneOntologyCellularComponent	adherens junction	LLGL2 PTPRM PSG2 PSG3 PSG11 NECTIN1 NECTIN2	2.16e-05	212	83	7	GO:0005912
GeneOntologyCellularComponent	transforming growth factor beta ligand-receptor complex	PSG2 PSG3 PSG11	3.26e-05	16	83	3	GO:0070021
GeneOntologyCellularComponent	PAM complex, Tim23 associated import motor	DNAJC19 DNAJC15	1.55e-04	5	83	2	GO:0001405
GeneOntologyCellularComponent	lateral plasma membrane	SLC6A9 PSG2 PSG3 PSG11	4.55e-04	90	83	4	GO:0016328
GeneOntologyCellularComponent	anchoring junction	FLNB CDSN LLGL2 PTPRM PSG2 PSG3 PSG11 NECTIN1 NECTIN2 PLEC TEC PHLDB2	4.56e-04	976	83	12	GO:0070161
GeneOntologyCellularComponent	cell-cell junction	CDSN LLGL2 PTPRM PSG2 PSG3 PSG11 NECTIN1 NECTIN2 TEC	5.55e-04	591	83	9	GO:0005911
GeneOntologyCellularComponent	apical part of cell	SLC6A9 FN1 PSG2 PSG3 MYO7B PSG11 TCIRG1 CASR PLEC	5.62e-04	592	83	9	GO:0045177
GeneOntologyCellularComponent	ciliary membrane	PSG2 PSG3 PSG11 SMO	6.29e-04	98	83	4	GO:0060170
GeneOntologyCellularComponent	parallel fiber to Purkinje cell synapse	SLC6A9 PCLO SCN8A	6.64e-04	43	83	3	GO:0098688
GeneOntologyCellularComponent	apical plasma membrane	SLC6A9 FN1 PSG2 PSG3 PSG11 TCIRG1 CASR PLEC	7.00e-04	487	83	8	GO:0016324
GeneOntologyCellularComponent	basal part of cell	SLC6A9 PSG2 PSG3 PSG11 CASR PLEC PHLDB2	7.64e-04	378	83	7	GO:0045178
GeneOntologyCellularComponent	cell body	FLNB IGF1 INHA PCLO SCN8A RDH5 CASR SMO C4BPA APOB SEZ6	1.09e-03	929	83	11	GO:0044297
GeneOntologyCellularComponent	TIM23 mitochondrial import inner membrane translocase complex	DNAJC19 DNAJC15	1.80e-03	16	83	2	GO:0005744
GeneOntologyCellularComponent	endoplasmic reticulum lumen	FN1 GAS6 RDH5 TXNDC16 APOB F9	2.08e-03	332	83	6	GO:0005788
GeneOntologyCellularComponent	hippocampal mossy fiber to CA3 synapse	SLC6A9 C1QL3 NECTIN1	2.41e-03	67	83	3	GO:0098686
GeneOntologyCellularComponent	platelet alpha granule lumen	IGF1 FN1 GAS6	2.41e-03	67	83	3	GO:0031093
GeneOntologyCellularComponent	endoplasmic reticulum-Golgi intermediate compartment	VMA21 FN1 INPP5B SMO	2.41e-03	141	83	4	GO:0005793
Domain	ig	PTPRM PSG2 PSG3 PSG11 NECTIN1 NECTIN2 IGDCC3	1.86e-05	190	81	7	PF00047
Domain	Immunoglobulin	PTPRM PSG2 PSG3 PSG11 NECTIN1 NECTIN2 IGDCC3	1.86e-05	190	81	7	IPR013151
Domain	Oxysterol-bd	OSBPL9 OSBPL11	1.19e-03	12	81	2	IPR000648
Domain	Oxysterol-bd_CS	OSBPL9 OSBPL11	1.19e-03	12	81	2	IPR018494
Domain	-	GAS6 F9	1.19e-03	12	81	2	4.10.740.10
Domain	Oxysterol_BP	OSBPL9 OSBPL11	1.19e-03	12	81	2	PF01237
Domain	Coagulation_fac_subgr_Gla_dom	GAS6 F9	1.19e-03	12	81	2	IPR017857
Domain	OSBP	OSBPL9 OSBPL11	1.19e-03	12	81	2	PS01013
Domain	V-set	PSG2 PSG3 PSG11 NECTIN1 NECTIN2	1.23e-03	184	81	5	PF07686
Domain	Gla	GAS6 F9	1.63e-03	14	81	2	PF00594
Domain	GLA	GAS6 F9	1.63e-03	14	81	2	SM00069
Domain	GLA_1	GAS6 F9	1.63e-03	14	81	2	PS00011
Domain	GLA_domain	GAS6 F9	1.63e-03	14	81	2	IPR000294
Domain	GLA_2	GAS6 F9	1.63e-03	14	81	2	PS50998
Domain	Ig_V-set	PSG2 PSG3 PSG11 NECTIN1 NECTIN2	1.74e-03	199	81	5	IPR013106
Domain	-	FLNB FN1 PTPRM PSG2 PSG3 PSG11 NECTIN1 NECTIN2 IGDCC3	2.27e-03	663	81	9	2.60.40.10
Domain	IG	PTPRM PSG2 PSG3 PSG11 NECTIN1 NECTIN2 IGDCC3	2.33e-03	421	81	7	SM00409
Domain	Ig_sub	PTPRM PSG2 PSG3 PSG11 NECTIN1 NECTIN2 IGDCC3	2.33e-03	421	81	7	IPR003599
Domain	FRI	CORIN SMO	3.36e-03	20	81	2	SM00063
Domain	Ig-like_fold	FLNB FN1 PTPRM PSG2 PSG3 PSG11 NECTIN1 NECTIN2 IGDCC3	3.45e-03	706	81	9	IPR013783
Domain	IGc2	PSG2 PSG3 PSG11 NECTIN1 IGDCC3	3.56e-03	235	81	5	SM00408
Domain	Ig_sub2	PSG2 PSG3 PSG11 NECTIN1 IGDCC3	3.56e-03	235	81	5	IPR003598
Domain	-	CORIN SMO	3.70e-03	21	81	2	1.10.2000.10
Domain	Ig_2	PSG2 PSG3 PSG11	3.93e-03	73	81	3	PF13895
Domain	Actinin_actin-bd_CS	FLNB PLEC	4.43e-03	23	81	2	IPR001589
Domain	ACTININ_2	FLNB PLEC	4.43e-03	23	81	2	PS00020
Domain	ACTININ_1	FLNB PLEC	4.43e-03	23	81	2	PS00019
Domain	Frizzled_dom	CORIN SMO	4.82e-03	24	81	2	IPR020067
Domain	FZ	CORIN SMO	4.82e-03	24	81	2	PS50038
Domain	Fz	CORIN SMO	4.82e-03	24	81	2	PF01392
Domain	IG_LIKE	PTPRM PSG2 PSG3 PSG11 NECTIN1 NECTIN2 IGDCC3	5.42e-03	491	81	7	PS50835
Domain	Ig-like_dom	PTPRM PSG2 PSG3 PSG11 NECTIN1 NECTIN2 IGDCC3	6.16e-03	503	81	7	IPR007110
Domain	TGF-beta-rel	BMP7 INHA	8.47e-03	32	81	2	IPR015615
Domain	C1Q	C1QL3 CAPRIN2	8.47e-03	32	81	2	SM00110
Domain	C1q	C1QL3 CAPRIN2	8.47e-03	32	81	2	PF00386
Domain	TGFb_CS	BMP7 INHA	8.47e-03	32	81	2	IPR017948
Pubmed	ORP10, a cholesterol binding protein associated with microtubules, regulates apolipoprotein B-100 secretion.	OSBPL9 OSBPL11 APOB	5.43e-08	4	84	3	22906437
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	PTPRM PSG2 PSG3 PSG11 NECTIN1 NECTIN2 IGDCC3	1.40e-07	162	84	7	25826454
Pubmed	Olfactory sensory experience regulates gliomagenesis via neuronal IGF1.	IGF1 NF1 TP53	4.72e-07	7	84	3	35545672
Pubmed	A ciliopathy complex at the transition zone protects the cilia as a privileged membrane domain.	PSG2 PSG3 PSG11 SMO	2.19e-06	38	84	4	22179047
Pubmed	A study to survey susceptible genetic factors responsible for troglitazone-associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus.	CYP2C19 IGF1 CYP2C9 RDH5	2.71e-06	40	84	4	12732844
Pubmed	The human plasma proteome: a nonredundant list developed by combination of four separate sources.	IGF1 FN1 C4BPA APOB F9 ITIH4	3.12e-06	165	84	6	14718574
Pubmed	A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	1985902
Pubmed	CEACAM1+ myeloid cells control angiogenesis in inflammation.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	19273835
Pubmed	Decreased osteoclastogenesis and high bone mass in mice with impaired insulin clearance due to liver-specific inactivation to CEACAM1.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	20044046
Pubmed	Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	32150576
Pubmed	Mouse hepatitis virus type 4 (JHM strains). induced fatal central nervous system disease. I. genetic control and murine neuron as the susceptible site of disease.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	6265583
Pubmed	CEACAM1 is a potent regulator of B cell receptor complex-induced activation.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	12832451
Pubmed	CEACAM1 confers resistance toward oxygen-induced vessel damage in a mouse model of retinopathy of prematurity.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	25406283
Pubmed	Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus-A59.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	8380065
Pubmed	The receptor for mouse hepatitis virus in the resistant mouse strain SJL is functional: implications for the requirement of a second factor for viral infection.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	1279194
Pubmed	Exogenous carcinoembryonic antigen-related cell adhesion molecule 1 suppresses 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in mice.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	25724769
Pubmed	High-fat diet amplifies renal renin angiotensin system expression, blood pressure elevation, and renal dysfunction caused by Ceacam1 null deletion.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	26374765
Pubmed	CEACAM1 deficiency delays important wound healing processes.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	22092845
Pubmed	Liver-specific reconstitution of CEACAM1 reverses the metabolic abnormalities caused by its global deletion in male mice.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	28913658
Pubmed	Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	8500759
Pubmed	Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	9343248
Pubmed	Ceacam1 deletion causes vascular alterations in large vessels.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	23800882
Pubmed	Role of Ceacam1 in VEGF induced vasculogenesis of murine embryonic stem cell-derived embryoid bodies in 3D culture.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	19285068
Pubmed	Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	1326665
Pubmed	Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	39168268
Pubmed	The expression of mouse biliary glycoprotein, a carcinoembryonic antigen-related gene, is down-regulated in malignant mouse tissues.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	8402684
Pubmed	Leptin Resistance Contributes to Obesity in Mice with Null Mutation of Carcinoembryonic Antigen-related Cell Adhesion Molecule 1.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	27002145
Pubmed	Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	21949477
Pubmed	Differential effects of prenatal stress on metabolic programming in diet-induced obese and dietary-resistant rats.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	26219866
Pubmed	Spatiotemporal expression of murine carcinoembryonic antigen (CEA) gene family members during mouse embryogenesis.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	2133556
Pubmed	Perturbation of lytic and latent gammaherpesvirus infection in the absence of the inhibitory receptor CEACAM1.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	19621080
Pubmed	Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	19358828
Pubmed	Carcinoembryonic antigen-related cell adhesion molecule 1 modulates vascular remodeling in vitro and in vivo.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	16680193
Pubmed	Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	34058224
Pubmed	Down-regulation of Bgp1(a) viral receptor by interferon-gamma is related to the antiviral state and resistance to mouse hepatitis virus 3 infection.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	10964771
Pubmed	In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	23935487
Pubmed	Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	25972571
Pubmed	Carcinoembryonic antigen-related cell adhesion molecule 1: a link between insulin and lipid metabolism.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	18544705
Pubmed	Expression of the mouse hepatitis virus receptor by central nervous system microglia.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	15220458
Pubmed	Cytokine-induced CEACAM1 expression on keratinocytes is characteristic for psoriatic skin and contributes to a prolonged lifespan of neutrophils.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	18843289
Pubmed	Amino acid substitutions and an insertion in the spike glycoprotein extend the host range of the murine coronavirus MHV-A59.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	15207636
Pubmed	CEACAM1: a key regulator of vascular permeability.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	21081647
Pubmed	Pregnancy-specific glycoprotein (PSG) in baboon (Papio hamadryas): family size, domain structure, and prediction of a functional region in primate PSGs.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	11133662
Pubmed	Targeted disruption of the Ceacam1 (MHVR) gene leads to reduced susceptibility of mice to mouse hepatitis virus infection.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	11483763
Pubmed	The spike glycoprotein of murine coronavirus MHV-JHM mediates receptor-independent infection and spread in the central nervous systems of Ceacam1a-/- Mice.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	18003729
Pubmed	Murine coronavirus receptors are differentially expressed in the central nervous system and play virus strain-dependent roles in neuronal spread.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	20739537
Pubmed	The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	27695943
Pubmed	Generation of human CEACAM1 transgenic mice and binding of Neisseria Opa protein to their neutrophils.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	20404914
Pubmed	Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	16638824
Pubmed	Insulin Sensitivity Is Retained in Mice with Endothelial Loss of Carcinoembryonic Antigen Cell Adhesion Molecule 1.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	34440862
Pubmed	Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	21670291
Pubmed	Investigations on the usefulness of CEACAMs as potential imaging targets for molecular imaging purposes.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	22162753
Pubmed	A mouse analogue of the human carcinoembryonic antigen.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	2702644
Pubmed	Activation-induced expression of carcinoembryonic antigen-cell adhesion molecule 1 regulates mouse T lymphocyte function.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	11801635
Pubmed	Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantation.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	21760897
Pubmed	Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	1719235
Pubmed	Deletion of the carcinoembryonic antigen-related cell adhesion molecule 1 (Ceacam1) gene contributes to colon tumor progression in a murine model of carcinogenesis.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	16619040
Pubmed	Carcinoembryonic antigen-related cell adhesion molecule 1 controls IL-2-dependent regulatory T-cell induction in immune-mediated hepatitis in mice.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	29377208
Pubmed	Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	8209741
Pubmed	CEACAM1 regulates CD8+ T cell immunity and protects from severe pathology during Citrobacter rodentium induced colitis.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	32521208
Pubmed	Targeted disruption of carcinoembryonic antigen-related cell adhesion molecule 1 promotes diet-induced hepatic steatosis and insulin resistance.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	19406938
Pubmed	CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	29967450
Pubmed	The mouse biliary glycoprotein gene (Bgp): partial nucleotide sequence, expression, and chromosomal assignment.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	1653760
Pubmed	Neutrophil Extracellular Trap-Associated CEACAM1 as a Putative Therapeutic Target to Prevent Metastatic Progression of Colon Carcinoma.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	32169849
Pubmed	Host-related carcinoembryonic antigen cell adhesion molecule 1 promotes metastasis of colorectal cancer.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	22469976
Pubmed	CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	21532628
Pubmed	Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	28035001
Pubmed	Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	15316023
Pubmed	Ceacam1a-/- mice are completely resistant to infection by murine coronavirus mouse hepatitis virus A59.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	15331748
Pubmed	Organ tropism of murine coronavirus does not correlate with the expression levels of the membrane-anchored or secreted isoforms of the carcinoembryonic antigen-related cell adhesion molecule 1 receptor.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	22673933
Pubmed	Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	22406619
Pubmed	Characterization and transcriptional activity of the mouse biliary glycoprotein 1 gene, a carcinoembryonic antigen-related gene.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	7628460
Pubmed	CEACAM1 negatively regulates platelet-collagen interactions and thrombus growth in vitro and in vivo.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	19008452
Pubmed	Purification of the 110-kilodalton glycoprotein receptor for mouse hepatitis virus (MHV)-A59 from mouse liver and identification of a nonfunctional, homologous protein in MHV-resistant SJL/J mice.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	2164599
Pubmed	Liver-specific rescuing of CEACAM1 reverses endothelial and cardiovascular abnormalities in male mice with null deletion of Ceacam1 gene.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	29396368
Pubmed	Hepatic CEACAM1 Over-Expression Protects Against Diet-Induced Fibrosis and Inflammation in White Adipose Tissue.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	26284027
Pubmed	CEACAM1 specifically suppresses B cell receptor signaling-mediated activation.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	33352461
Pubmed	Loss of CEACAM1 in hepatocytes causes hepatic fibrosis.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	38381498
Pubmed	mmCGM1a: a mouse carcinoembryonic antigen gene family member, generated by alternative splicing, functions as an adhesion molecule.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	1633107
Pubmed	Loss of CEACAM1, a Tumor-Associated Factor, Attenuates Post-infarction Cardiac Remodeling by Inhibiting Apoptosis.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	26911181
Pubmed	Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	32027621
Pubmed	Hyperinsulinemia drives hepatic insulin resistance in male mice with liver-specific Ceacam1 deletion independently of lipolysis.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	30664851
Pubmed	Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	27777319
Pubmed	Development of nonalcoholic steatohepatitis in insulin-resistant liver-specific S503A carcinoembryonic antigen-related cell adhesion molecule 1 mutant mice.	PSG2 PSG3 PSG11	3.82e-06	13	84	3	18848945
Pubmed	Alternative splicing of CEACAM1 by hypoxia-inducible factor-1α enhances tolerance to hepatic ischemia in mice and humans.	PSG2 PSG3 PSG11	4.85e-06	14	84	3	37531413
Pubmed	Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36.	PSG2 PSG3 PSG11	4.85e-06	14	84	3	34666041
Pubmed	Mice Lacking PECAM-1 and Ceacam1 Have Enhanced Platelet Secretion and Thrombus Growth: Novel Link with PAR4.	PSG2 PSG3 PSG11	4.85e-06	14	84	3	34619794
Pubmed	Biliary glycoprotein 1 expression during embryogenesis: correlation with events of epithelial differentiation, mesenchymal-epithelial interactions, absorption, and myogenesis.	PSG2 PSG3 PSG11	4.85e-06	14	84	3	8896983
Pubmed	Acceleration of collateral development by carcinoembryonic antigen-related cell adhesion molecule 1 expression on CD11b/⁺Gr-1⁺ myeloid cells--brief report.	PSG2 PSG3 PSG11	4.85e-06	14	84	3	22962327
Pubmed	The cell adhesion receptor carcinoembryonic antigen-related cell adhesion molecule 1 regulates nucleocytoplasmic trafficking of DNA polymerase delta-interacting protein 38.	PSG2 PSG3 PSG11	4.85e-06	14	84	3	17623671
Pubmed	PPARα (Peroxisome Proliferator-activated Receptor α) Activation Reduces Hepatic CEACAM1 Protein Expression to Regulate Fatty Acid Oxidation during Fasting-refeeding Transition.	PSG2 PSG3 PSG11	4.85e-06	14	84	3	26846848
Pubmed	CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium.	PSG2 PSG3 PSG11	4.85e-06	14	84	3	18794798
Pubmed	Protein kinase Cε modulates insulin receptor localization and trafficking in mouse embryonic fibroblasts.	PSG2 PSG3 PSG11	4.85e-06	14	84	3	23469261
Pubmed	Intestinal tumor progression is promoted by decreased apoptosis and dysregulated Wnt signaling in Ceacam1-/- mice.	PSG2 PSG3 PSG11	4.85e-06	14	84	3	18454175
Pubmed	NLRC5 deficiency protects against acute kidney injury in mice by mediating carcinoembryonic antigen-related cell adhesion molecule 1 signaling.	PSG2 PSG3 PSG11	4.85e-06	14	84	3	29907459
Pubmed	Neutrophil CEACAM1 determines susceptibility to NETosis by regulating the S1PR2/S1PR3 axis in liver transplantation.	PSG2 PSG3 PSG11	4.85e-06	14	84	3	36719377
Pubmed	Age-dependent insulin resistance in male mice with null deletion of the carcinoembryonic antigen-related cell adhesion molecule 2 gene.	PSG2 PSG3 PSG11	4.85e-06	14	84	3	28567513
Pubmed	Bgp2, a new member of the carcinoembryonic antigen-related gene family, encodes an alternative receptor for mouse hepatitis viruses.	PSG2 PSG3 PSG11	4.85e-06	14	84	3	8207827
Pubmed	Carcinoembryonic antigen-related cell adhesion molecule 1 modulates experimental autoimmune encephalomyelitis via an iNKT cell-dependent mechanism.	PSG2 PSG3 PSG11	4.85e-06	14	84	3	19700760
Pubmed	Expression of transgenic carcinoembryonic antigen (CEA) in tumor-prone mice: an animal model for CEA-directed tumor immunotherapy.	PSG2 PSG3 PSG11	4.85e-06	14	84	3	9212243
Cytoband	19q13.2	PSG3 PSG11 NECTIN2 TEC	2.42e-04	164	84	4	19q13.2
GeneFamily	CD molecules\|V-set domain containing\|Pregnancy specific glycoproteins	PSG2 PSG3 PSG11	5.08e-06	11	58	3	1315
GeneFamily	Adenosine receptors\|V-set domain containing	PSG2 PSG3 PSG11 NECTIN1 NECTIN2	1.75e-04	163	58	5	590
GeneFamily	Oxysterol binding proteins\|Pleckstrin homology domain containing	OSBPL9 OSBPL11	6.54e-04	12	58	2	670
GeneFamily	Gla domain containing	GAS6 F9	7.71e-04	13	58	2	1250
GeneFamily	Zinc fingers\|Zinc fingers PARP-type\|Poly(ADP-ribose) polymerases	TRAF3 PCLO	1.03e-03	15	58	2	26
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	OSBPL9 OSBPL11 TEC PHLDB2	4.30e-03	206	58	4	682
GeneFamily	Cytochrome P450 family 2	CYP2C19 CYP2C9	5.62e-03	35	58	2	1001
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	NECTIN1 NECTIN2	7.30e-03	40	58	2	592
Coexpression	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS	BROX CYP2C19 CYP2C9 IPO8 PSG2 PSG3 INHA PSG11 SCN8A FKBP9 TCIRG1 TEC MBD2 HR	5.68e-07	871	83	14	MM1005
Coexpression	OHGUCHI_LIVER_HNF4A_TARGETS_DN	CYP2C19 CYP2C9 PSG2 PSG3 PSG11 RDH5 C4BPA	3.56e-06	201	83	7	MM1294
Coexpression	OUYANG_PROSTATE_CANCER_MARKERS	FN1 PSG2 PSG3 PSG11	4.54e-06	35	83	4	MM757
Coexpression	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	ABHD4 STRAP PTPRM TMEM41A INPP5B CAPRIN2 FKBP9 RDH5 TCIRG1 PLEC MAPKBP1 CLP1 LACTB HR	1.43e-05	1151	83	14	M1103
Coexpression	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP	SLC6A9 CYP2C19 CYP2C9 STRAP SPTLC1 TXNDC16 XDH PLEC TP53 PHLDB2	2.49e-05	616	83	10	MM977
Coexpression	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	ABHD4 STRAP PTPRM TMEM41A INPP5B CAPRIN2 FKBP9 RDH5 TCIRG1 PLEC MAPKBP1 CLP1 LACTB HR	2.87e-05	1226	83	14	MM979
Coexpression	GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN	NF1 PTPRM TCIRG1 ERMP1 MBD2 PHLDB2	4.12e-05	199	83	6	M6519
Coexpression	GSE39152_SPLEEN_CD103_NEG_VS_BRAIN_CD103_POS_MEMORY_CD8_TCELL_DN	BMP7 CDSN INHA TCIRG1 C4BPA SEZ6	4.24e-05	200	83	6	M9067
Coexpression	OLSSON_E2F3_TARGETS_UP	TM9SF2 NECTIN1 LAMA4	7.55e-05	26	83	3	M18325
Coexpression	NABA_MATRISOME	INTS6L BMP7 IGF1 FN1 INHA SFTPD C1QL3 GAS6 LAMA4 C4BPA F9 ITIH4	7.67e-05	1008	83	12	MM17056
Coexpression	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP	SLC6A9 CYP2C19 STRAP SPTLC1 TXNDC16 XDH PLEC TP53 PHLDB2	7.72e-05	567	83	9	M1097
Coexpression	MILI_PSEUDOPODIA_CHEMOTAXIS_DN	FLNB TM9SF2 FN1 MACO1 SPTLC1 OSBPL9 DNAAF9 SBNO2	1.01e-04	457	83	8	M1613
Coexpression	MILI_PSEUDOPODIA_CHEMOTAXIS_DN	FLNB TM9SF2 FN1 MACO1 SPTLC1 OSBPL9 DNAAF9 SBNO2	1.23e-04	470	83	8	MM1053
Coexpression	KESHELAVA_MULTIPLE_DRUG_RESISTANCE	FN1 INPP5B ODF2 SBNO2	1.35e-04	82	83	4	M12618
Coexpression	GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS	PSG2 PSG3 PSG11	1.42e-04	32	83	3	MM2
Coexpression	WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN	CYP2C19 CYP2C9	1.47e-04	6	83	2	MM971
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	FLNB ALMS1 PTPRM C1QL3 SCN8A OSBPL9 ERMP1 DNAAF9 PLEC MBD2 PHLDB2 HR	1.77e-04	1102	83	12	M2369
Coexpression	NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR	FN1 SFTPD LAMA4	1.86e-04	35	83	3	MM17054
Coexpression	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS	BROX CYP2C19 IPO8 INHA SCN8A FKBP9 TCIRG1 TEC MBD2 HR	1.87e-04	786	83	10	M2388
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	FLNB ALMS1 PTPRM C1QL3 SCN8A OSBPL9 ERMP1 DNAAF9 PLEC MBD2 PHLDB2 HR	2.12e-04	1124	83	12	MM1070
Coexpression	BERENJENO_TRANSFORMED_BY_RHOA_DN	FN1 PTPRM GAS6 FKBP9 LAMA4 TXNDC16 XDH	2.72e-04	398	83	7	M7514
Coexpression	TCGA_GLIOBLASTOMA_MUTATED	NF1 TP53	2.74e-04	8	83	2	M19387
Coexpression	MCBRYAN_PUBERTAL_BREAST_4_5WK_UP	FN1 PSG2 PSG3 PSG11 GAS6 TXNDC16	2.88e-04	284	83	6	MM987
Coexpression	AIZARANI_LIVER_C17_HEPATOCYTES_3	CYP2C19 CYP2C9 FN1 APOB	3.14e-04	102	83	4	M39119
Coexpression	NABA_ECM_GLYCOPROTEINS	INTS6L FN1 GAS6 LAMA4 C4BPA	3.57e-04	191	83	5	MM17059
Coexpression	AIZARANI_LIVER_C11_HEPATOCYTES_1	CYP2C19 CYP2C9 FN1 C4BPA APOB F9	3.72e-04	298	83	6	M39115
Coexpression	BERENJENO_TRANSFORMED_BY_RHOA_DN	FN1 PTPRM GAS6 FKBP9 LAMA4 TXNDC16 XDH	3.81e-04	421	83	7	MM985
Coexpression	NABA_MATRISOME	INTS6L BMP7 IGF1 FN1 INHA SFTPD C1QL3 GAS6 LAMA4 F9 ITIH4	3.84e-04	1026	83	11	M5889
Coexpression	GSE27291_0H_VS_6H_STIM_GAMMADELTA_TCELL_UP	VMA21 PTPRM TMEM209 TP53 SBNO2	3.93e-04	195	83	5	M8446
Coexpression	GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP	SLC6A9 NF1 PTPRM PSG3 PCLO	4.02e-04	196	83	5	M8135
Coexpression	GSE26559_TCF1_KO_VS_WT_LIN_NEG_CELL_DN	SLC6A9 CYP2C19 PSG11 C4BPA HR	4.02e-04	196	83	5	M8422
Coexpression	GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_UP	NF1 SFTPD PCLO GAS6 HR	4.12e-04	197	83	5	M4985
Coexpression	GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN	BROX LLGL2 NF1 PTPRM TCIRG1	4.21e-04	198	83	5	M6511
Coexpression	GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_UP	FLNB CAPRIN2 SCN8A LAMA4 ITIH4	4.21e-04	198	83	5	M5577
Coexpression	GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_DN	INTS6L DNAJC15 SPTLC1 APOB LACTB	4.31e-04	199	83	5	M7017
Coexpression	GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN	TRAF3 CAPRIN2 TMEM209 DNAAF9 PLEC	4.31e-04	199	83	5	M6030
Coexpression	GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_DN	INTS6L OSBPL9 TXNDC16 DNAAF9 MBD2	4.41e-04	200	83	5	M8956
Coexpression	GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_DN	ORC5 TM9SF2 SPTLC1 CLP1 ITIH4	4.41e-04	200	83	5	M5841
Coexpression	GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN	NF1 PTPRM TCIRG1 ERMP1 UBN2	4.41e-04	200	83	5	M6513
Coexpression	GSE39152_CD103_NEG_VS_POS_MEMORY_CD8_TCELL_UP	IGF1 NF1 IGDCC3 TEC F9	4.41e-04	200	83	5	M9073
Coexpression	GSE39152_BRAIN_VS_SPLEEN_CD103_NEG_MEMORY_CD8_TCELL_UP	CYP2C19 IGF1 PLEC TEC MBD2	4.41e-04	200	83	5	M9075
Coexpression	GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN	TRAF3 OSBPL11 TXNDC16 TCIRG1 XDH	4.41e-04	200	83	5	M6237
Coexpression	GSE40274_HELIOS_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	PTPRM C1QL3 PLEC TEC LACTB	4.41e-04	200	83	5	M9166
Coexpression	GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_DN	TRAF3 FN1 FKBP9 ERMP1 DNAAF9	4.41e-04	200	83	5	M7361
Coexpression	GSE19888_NO_PRETREAT_VS_ADENOSINE_A3R_INHIBITOR_PRETREATED_MAST_CELL_TCELL_MEMBRANES_ACT_UP	VMA21 IPO8 INPP5B DGCR8 F9	4.41e-04	200	83	5	M7354
ToppCell	COVID-19-kidney-PCT-S3-2\|kidney / Disease (COVID-19 only), tissue and cell type	IGF1 CYP2C9 C4BPA APOB F9 ITIH4	9.72e-07	174	84	6	5aa2fb631505600f37d2b87b02def7be139dc262
ToppCell	(2)_5-FU-(3)_LEPR+_perivascular_cells\|World / Stress and Cell class	IGF1 ARRDC4 GAS6 FKBP9 SMO ERMP1	2.00e-06	197	84	6	434ae0231972acba12d06279908cf407e70511ac
ToppCell	390C-Epithelial_cells-Epithelial-A_(AT2)\|390C / Donor, Lineage, Cell class and subclass (all cells)	SLC6A9 SFTPD PCLO C4BPA ITIH4	1.31e-05	160	84	5	731def6d82814ebac1a400bc7aea5f6da43ec960
ToppCell	390C-Epithelial_cells-Epithelial-A_(AT2)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	SLC6A9 SFTPD PCLO C4BPA ITIH4	1.31e-05	160	84	5	cf27b4ac4d0caa6f9b068dc8ea93472470a01a4d
ToppCell	droplet-Liver-HEPATOCYTES-1m-Epithelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A9 FN1 APOB F9 ITIH4	1.66e-05	168	84	5	b98af4043dfa5dfa4413e482879fad88de484675
ToppCell	droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A9 FN1 APOB F9 ITIH4	1.66e-05	168	84	5	073b53d4cee6bc8c5c6fce51cf6cd9c316478f69
ToppCell	droplet-Liver-HEPATOCYTES\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A9 FN1 APOB F9 ITIH4	1.71e-05	169	84	5	f195467438c589f87224bde7da720dea072d110c
ToppCell	droplet-Liver-HEPATOCYTES-1m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A9 FN1 APOB F9 ITIH4	1.71e-05	169	84	5	7785cab967a33560830c394c918d6ce625103858
ToppCell	droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Periportal)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A9 FN1 APOB F9 ITIH4	2.02e-05	175	84	5	5c38d4b6c03473d841e6203a7efaa6dcb2d59386
ToppCell	AT1-AT2_cells-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	FLNB LLGL2 GAS6 C4BPA PHLDB2	2.02e-05	175	84	5	bdd85ba280648a0283c1984662a34c7b840f64dd
ToppCell	TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma\|TCGA-Cervix / Sample_Type by Project: Shred V9	BMP7 TMEM41A NECTIN1 MBD2 PHLDB2	2.08e-05	176	84	5	8513c2a05a34453a16bbcf1c11cb34c580133e47
ToppCell	droplet-Lung-nan-3m-Epithelial\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LLGL2 SFTPD NECTIN2 CAPRIN2 ITIH4	2.44e-05	182	84	5	cfba75c1ffc39ac76db9e8e27394731942882b30
ToppCell	droplet-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LLGL2 SFTPD NECTIN2 CAPRIN2 ITIH4	2.44e-05	182	84	5	d836bfdc298ecd3558a973e393a329eb8bd59d79
ToppCell	droplet-Lung-nan-3m-Epithelial-type_II_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LLGL2 SFTPD NECTIN2 CAPRIN2 ITIH4	2.44e-05	182	84	5	7e7c7a26460d3003cdf0c0ffb96208a566aa09a7
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SLC6A9 CYP2C9 C4BPA APOB F9	2.78e-05	187	84	5	edb0ab0154542b1c0b3a2c216c4a60f0f06290b3
ToppCell	Macrophages-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	FN1 MYO7B ARRDC4 OSBPL11 TCIRG1	2.93e-05	189	84	5	c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SLC6A9 CYP2C9 C4BPA APOB F9	2.93e-05	189	84	5	7899af78b273d9c7f029d52f7e0cf6df4da41f5e
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SLC6A9 CYP2C9 C4BPA APOB F9	3.00e-05	190	84	5	a34293601aefe5fb5c400c14091294b9ddaa195b
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNB FN1 DNAJC15 PLEC LACTB	3.23e-05	193	84	5	5a201ee6f132357c9aacfbad3ae56ed9854c25fd
ToppCell	(2)_5-FU-(3)_LEPR+_perivascular_cells\|(2)_5-FU / Stress and Cell class	IGF1 ARRDC4 GAS6 SMO ERMP1	3.48e-05	196	84	5	cc0a172de71d9a1a882c9e78652dae70e007d012
ToppCell	facs-Lung-nan\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGF1 TM9SF2 GAS6 LAMA4 XDH	3.48e-05	196	84	5	b05f77f3990b662682ffeaf0e4c2fb190e0a6e65
ToppCell	facs-Lung-nan-3m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGF1 TM9SF2 GAS6 LAMA4 XDH	3.48e-05	196	84	5	787c6cd92035e0b1108c2c086c42a229016e476b
ToppCell	AT1_cells-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	FLNB LLGL2 GAS6 C4BPA PHLDB2	3.57e-05	197	84	5	80d81be244c94c435accb643449b4ce6a3462c7f
ToppCell	Fibroblasts-CD34+_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	IGF1 FN1 GAS6 LAMA4 PHLDB2	3.74e-05	199	84	5	13ff7409e200a0b46cdb7924d15ef33639693622
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LLGL2 GAS6 TCIRG1 PLEC CLP1	3.83e-05	200	84	5	88d713dfc792e7609bf7ecfb28f87cb748088570
ToppCell	background-Hepatocytes\|background / Sample and Cell Type and Tumor Cluster (all cells)	CYP2C9 FN1 C4BPA APOB F9	3.83e-05	200	84	5	787d35b5c2f2ad967ae14e99496a0299ac7e72fd
ToppCell	droplet-Liver-nan-3m-Epithelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGF1 FN1 APOB ITIH4	2.22e-04	157	84	4	b72c6a1ed17bfc32d9dec193d934ea82e80b6bd5
ToppCell	droplet-Liver-HEPATOCYTES-1m-Epithelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A9 FN1 APOB ITIH4	2.27e-04	158	84	4	9f58428f70d1427b20122c5c1cc7bf521d0f4832
ToppCell	facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A9 IGF1 FN1 ITIH4	2.38e-04	160	84	4	56e6f4b82b5dc41c45f9d253c2db314a6f702b84
ToppCell	facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A9 IGF1 FN1 ITIH4	2.38e-04	160	84	4	bb1b966fb9e801db15e67d03e49db4609d6f935a
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FN1 TCIRG1 TEC MBD2	2.38e-04	160	84	4	6ed37d1fd0304932319d6b942502404115ff36a7
ToppCell	facs-Marrow-Granulocytes-18m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A9 IGF1 FN1 ITIH4	2.44e-04	161	84	4	60f433eab9d5531bdf6aa86b0265f20b866b904c
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L4\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	NECTIN1 LAMA4 KCNH5 HR	2.56e-04	163	84	4	1e8ab00ecc2d2ba35aa6745c0ed38663e26312e8
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	NECTIN1 LAMA4 KCNH5 HR	2.56e-04	163	84	4	431221a41d396b09170476179590eaf8a55266d8
ToppCell	10x5'-blood-Lymphocytic_NK-NK_CD56bright_CD16-\|blood / Manually curated celltypes from each tissue	FLNB SMO TEC PHLDB2	2.74e-04	166	84	4	ba42349a68b22e91a0340bda1ccecd6c7592392f
ToppCell	mild_COVID-19_(asymptomatic)-pDC\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	BMP7 INHA NECTIN1 GAS6	2.87e-04	168	84	4	968405ea56f7d001ef83ff9274610923c3b2d55d
ToppCell	368C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	BROX ARRDC4 GAS6 FKBP9	2.93e-04	169	84	4	0589f39d8e9468e42d25d30ff70bb7cb8b921628
ToppCell	cellseq2-Epithelial-Epithelial_Airway-Secretory/RAS\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CYP2C9 VMA21 C4BPA HR	3.00e-04	170	84	4	b62f7184e78e9672ea88e361654f604f9df2dc5f
ToppCell	facs-Marrow-B-cells-18m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 TLDC2 NECTIN1 RDH5	3.00e-04	170	84	4	6e82e41acd1299aa549a32ac036b39754abdf376
ToppCell	cellseq2-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CYP2C9 VMA21 C4BPA HR	3.00e-04	170	84	4	00fe77bca9c28762212c498f9c49e14cb1492cca
ToppCell	facs-Marrow-B-cells-18m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 TLDC2 NECTIN1 RDH5	3.00e-04	170	84	4	18cd941bf3ca7cc0b6af1317bd2619d283353de0
ToppCell	facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LLGL2 CAPRIN2 CORIN ITIH4	3.07e-04	171	84	4	b54d9d6b03c9c6f28a71cf2ed2bfa9a335bba949
ToppCell	facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LLGL2 CAPRIN2 CORIN ITIH4	3.07e-04	171	84	4	9d825a2e799421af4f2cf4f4dc8e239b5d00476d
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-8\|TCGA-Liver / Sample_Type by Project: Shred V9	ARRDC4 GAS6 XDH F9	3.07e-04	171	84	4	c4a919fe3d56ae6df2fcab6686abacc10befc053
ToppCell	AT1_cells-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	LLGL2 MYO7B GAS6 PHLDB2	3.21e-04	173	84	4	b29816427428c7053017477f59b828bf1357f3b2
ToppCell	TCGA-Liver\|World / Sample_Type by Project: Shred V9	CYP2C9 APOB F9 ITIH4	3.28e-04	174	84	4	452932f08cf53e5949672a025d78cecb874aa4b0
ToppCell	NS-moderate-d_0-4-Epithelial-Ionocyte\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	IGF1 GAS6 LAMA4 PHLDB2	3.35e-04	175	84	4	a1e0a15c69211d6db2edeb101476f0f6e08b90c8
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CYP2C9 LLGL2 RDH5 XDH	3.35e-04	175	84	4	6759d200a133034756de9cdf2d5daceca927aac9
ToppCell	(0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells\|World / Stress and Cell class	IGF1 ARRDC4 GAS6 FKBP9	3.42e-04	176	84	4	ce2c32b5ce0da848eb4da35ce4d215cdf74d9113
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A9 IGF1 DHX34 ITIH4	3.42e-04	176	84	4	60740f676db5d259ef3046bd5bc7b7b14924ecee
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	FN1 MYO7B NECTIN2 GAS6	3.50e-04	177	84	4	3a94ee9b58ebdbbc75e00954cf1f6922f88f8f88
ToppCell	facs-Lung-EPCAM-3m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP7 IGF1 IGDCC3 HR	3.57e-04	178	84	4	27497dbfcf9bb4dd0bf7caa0bd78c7e85f5c18ee
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7\|TCGA-Colorectal / Sample_Type by Project: Shred V9	FN1 FKBP9 LAMA4 CORIN	3.57e-04	178	84	4	edc76b8f15056ec1c9a1c61a048b6331a92592d6
ToppCell	facs-Lung-EPCAM-3m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP7 IGF1 IGDCC3 HR	3.57e-04	178	84	4	d348a9550db940d204706529759dc51e30506b5f
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYO7B NECTIN1 NECTIN2 GAS6	3.65e-04	179	84	4	ba64bfb757d6e3be631ee95abfa24b47861f6a14
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	INTS6L ABHD4 MAPKBP1 ITIH4	3.65e-04	179	84	4	6bbb32d7e582a96cb3cfc3eb911b05d518e7d5e9
ToppCell	Globus_pallidus-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Kif5b_(Kif5b)-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	MYO7B SFTPD SPTLC1	3.70e-04	74	84	3	ebd6571675c446406c0e421537b0a4d38c9d8f10
ToppCell	Globus_pallidus-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Kif5b_(Kif5b)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	MYO7B SFTPD SPTLC1	3.70e-04	74	84	3	96bee94904be2d022a6228d4c22b28ea34060407
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-mesothelial_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SFTPD C4BPA PHLDB2 KCNH5	3.80e-04	181	84	4	65eaa9bc1022bcf0c5f0f92c07a2cbbf11f9b59c
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(PRG4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SFTPD C4BPA PHLDB2 KCNH5	3.80e-04	181	84	4	eaac7d58117eddfff06b25521efc431c1351d592
ToppCell	facs-Pancreas-Exocrine\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A9 IGF1 GAS6 LAMA4	3.88e-04	182	84	4	45faefd7cbeac84d2c58650530b902af6ce921f8
ToppCell	COPD-Epithelial-ATI\|World / Disease state, Lineage and Cell class	LLGL2 SFTPD GAS6 PHLDB2	3.88e-04	182	84	4	e95d946a43b1579af199900bb0e3eacbb9d65300
ToppCell	facs-Kidney-nan-3m\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BROX PTPRM CASR ERMP1	3.88e-04	182	84	4	4c5d14e33ebdf117b5aa9e2f57aaa89aa51f72bf
ToppCell	droplet-Thymus-nan-18m-Myeloid\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SFTPD NECTIN2 GAS6 PHLDB2	3.88e-04	182	84	4	f6717e97e87513384149800c9fd8dea821ab9393
ToppCell	droplet-Thymus-nan-18m-Myeloid-professional_antigen_presenting_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SFTPD NECTIN2 GAS6 PHLDB2	3.88e-04	182	84	4	c33b0d532822186a1e8e645500347972468718c0
ToppCell	3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CYP2C19 TLDC2 PCLO CASR	3.96e-04	183	84	4	d23018193b9c0806e0d1a9ac15e6392eb8e96aaf
ToppCell	PND07-28-samps-Epithelial-Alveolar_epithelial\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	LLGL2 SFTPD NECTIN1 ITIH4	3.96e-04	183	84	4	23e55f88a802a9299d2773f9394970e86e8bbfaa
ToppCell	PND07-28-samps-Epithelial-Alveolar_epithelial-AT2\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	LLGL2 SFTPD NECTIN1 ITIH4	3.96e-04	183	84	4	0a69e22750dd8b66ab988cf36d0dd2b59e2f7d26
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PCLO LAMA4 PHLDB2 KCNH5	3.96e-04	183	84	4	274076a0978bce2bd53a1732045f18ef0f2d9985
ToppCell	AT1-AT2_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	FLNB PCLO GAS6 PHLDB2	3.96e-04	183	84	4	6821dca076318115d360ff426eb1218cfe104063
ToppCell	343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	UBN2 LACTB SBNO2 SEZ6	4.05e-04	184	84	4	2c2125b8030af83f7a6d59a7102d4de8e0ac1988
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	INTS6L LAMA4 TEC KCNH5	4.05e-04	184	84	4	6475a43201b136dcc9b113d2ca4cfa154ed9d65d
ToppCell	Control-Epithelial-ATI\|World / Disease state, Lineage and Cell class	LLGL2 SFTPD GAS6 PHLDB2	4.13e-04	185	84	4	0563d5042bb96ecce8446fbf26d05ef7a45e23c5
ToppCell	droplet-Marrow-BM-30m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNB FN1 DNAJC15 PLEC	4.22e-04	186	84	4	bcb3ac9f9b51346e0a2b0bda96d149b3c11f7883
ToppCell	IPF-Epithelial-ATI\|Epithelial / Disease state, Lineage and Cell class	SFTPD GAS6 C4BPA PHLDB2	4.22e-04	186	84	4	d436ee6cabbde8553ec5e6e55022274090d9f41a
ToppCell	Mesenchymal_cells-Adipo-CAR\|World / Lineage and Cell class	IGF1 ARRDC4 GAS6 FKBP9	4.22e-04	186	84	4	6ca8ce7ced91d6308b7c056032ffec1b37c974bf
ToppCell	droplet-Lung-LUNG-1m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A9 PCLO NECTIN2 LAMA4	4.30e-04	187	84	4	9c9ae8725905ba0cfe407878006ed06c2480fb72
ToppCell	droplet-Lung-LUNG-1m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A9 PCLO NECTIN2 LAMA4	4.30e-04	187	84	4	9e9460e57cdc9cd0a0de2866b140e06d0bc19a8f
ToppCell	droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLC6A9 PCLO NECTIN2 LAMA4	4.39e-04	188	84	4	dc52dd2957be3f40001f0a56f3d9ac9d66ea466e
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D175\|Adult / Lineage, Cell type, age group and donor	SLC6A9 SFTPD PCLO C4BPA	4.39e-04	188	84	4	ec38def1fdbb34ed9b30244806975bd5a4370164
ToppCell	droplet-Lung-1m-Endothelial-lymphatic_endothelial\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLC6A9 PCLO NECTIN2 LAMA4	4.39e-04	188	84	4	2ef08313087e91985bcffc46c3798470cdeec49c
ToppCell	droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLC6A9 PCLO NECTIN2 LAMA4	4.39e-04	188	84	4	1f1604b6dc0a8ad0be3d9aac0bef448459c22465
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FLNB IGF1 LAMA4 PHLDB2	4.39e-04	188	84	4	aeecbc057dc823f8fcea8a98f18d213bacc7f4db
ToppCell	Fibroblast-C\|World / shred on cell class and cell subclass (v4)	BMP7 IGF1 FN1 FKBP9	4.48e-04	189	84	4	58e0400fbab5a0755504275aef5cf7986149abab
ToppCell	Globus_pallidus-Endothelial\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	LLGL2 LAMA4 TEC PHLDB2	4.48e-04	189	84	4	ad7dc9d25edd68fb624380a082c389fe7d640e7d
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	BMP7 IGF1 PTPRM TBL1Y	4.48e-04	189	84	4	979b7fa947538aa7ca4a219263da2575869a2caa
ToppCell	Adult\|World / Lineage, Cell type, age group and donor	LLGL2 SFTPD TCIRG1 C4BPA	4.48e-04	189	84	4	5cd285bfad973125d46d704fec18b21266a63379
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D231\|Adult / Lineage, Cell type, age group and donor	CDSN LLGL2 GAS6 PHLDB2	4.48e-04	189	84	4	5a04cb25f8f0447b2cecdb6c3695029281aca26d
ToppCell	droplet-Lung-3m\|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IGF1 GAS6 FKBP9 LAMA4	4.48e-04	189	84	4	5a636e952da9b1fd26aa17f7b129054f2da322b5
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	IGF1 PTPRM TBL1Y NECTIN2	4.57e-04	190	84	4	56cc761e50fddfb5366391518b4d8e16589b6b42
ToppCell	(1)_Control_(PBS)-(3)_LEPR+_perivascular_cells\|World / Stress and Cell class	IGF1 ARRDC4 GAS6 FKBP9	4.57e-04	190	84	4	ec0ab31266583a0966ac7615d5c0fabb7b7e66e8
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	IGF1 PTPRM TBL1Y NECTIN2	4.57e-04	190	84	4	25d4b591f75c26e404a34c42f1742d580af6598d
ToppCell	IPF-Myeloid-Macrophage_Alveolar\|Myeloid / Disease state, Lineage and Cell class	FN1 PTPRM ARRDC4 OSBPL11	4.57e-04	190	84	4	2592765016f291565697265800a232b2edef3792
ToppCell	facs-GAT-Fat-3m\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGF1 TM9SF2 GAS6 FKBP9	4.57e-04	190	84	4	1d92be1b41cff59e834a9d28868f554bd1f3e471
ToppCell	COPD-Myeloid-Macrophage_Alveolar\|Myeloid / Disease state, Lineage and Cell class	FN1 PTPRM ARRDC4 OSBPL11	4.57e-04	190	84	4	9fc763d65470ba8858b973689c4d4358faab7dd3
ToppCell	droplet-Marrow-nan-24m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNB FN1 DNAJC15 LACTB	4.57e-04	190	84	4	e2fdbfaf08da3274b6bdda615386aa880040a90a
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	IGF1 PTPRM TBL1Y IRX6	4.57e-04	190	84	4	be2b184a3559da41ba387ae0fdbeb9ae532868a5
ToppCell	droplet-Lung-1m-Mesenchymal-fibroblast\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IGF1 GAS6 FKBP9 LAMA4	4.66e-04	191	84	4	ce80f65bd24b1c4d2152bf45248449e7a1a97e56
ToppCell	5'\|World / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TM9SF2 SPTLC1 TCIRG1 PLEC	4.66e-04	191	84	4	0e752756e9d1b444930522efc0fdca072d42535f
ToppCell	Basal_cells-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	BMP7 NECTIN1 KCNH5 HR	4.66e-04	191	84	4	a98915bad9a4a61dd4cbca798914849b805f4a19
Computational	Liver genes - metabolism and xenobiotics.	CYP2C19 IGF1 CYP2C9 LLGL2 FN1 NECTIN2 TCIRG1 XDH C4BPA APOB ITIH4 SBNO2	1.72e-05	563	54	12	MODULE_23
Computational	Neighborhood of IGFBP1	CYP2C9 C4BPA APOB F9	1.84e-04	57	54	4	CAR_IGFBP1
Computational	Neighborhood of IGF1	IGF1 CYP2C9 ITIH4	2.87e-04	26	54	3	GNF2_IGF1
Computational	Neighborhood of HPX	CYP2C9 C4BPA APOB F9	4.79e-04	73	54	4	CAR_HPX
Drug	(S)-(-)-Cycloserine [339-72-0]; Up 200; 39.2uM; PC3; HT_HG-U133A	IGF1 CYP2C9 NF1 TBL1Y RDH5 MBD2 DHX34 HR	5.71e-07	195	83	8	3789_UP
Drug	Suramin sodium salt; Up 200; 10uM; MCF7; HT_HG-U133A	NF1 INHA PCLO CAPRIN2 SCN8A TMEM209 DGCR8 DHX34	6.41e-07	198	83	8	7524_UP
Drug	Azaperone [1649-18-9]; Up 200; 12.2uM; MCF7; HT_HG-U133A	TRAF3 NF1 IPO8 INPP5B TMEM209 MBD2 DHX34 SBNO2	6.66e-07	199	83	8	7231_UP
Drug	dihydrocapsaicin	CYP2C19 IGF1 CYP2C9 TP53	7.61e-07	20	83	4	ctd:C012906
Drug	Implanon	CYP2C19 CYP2C9 OSBPL9 OSBPL11 APOB	7.75e-07	47	83	5	CID000040976
Drug	kalinin	FN1 LAMA4 TCIRG1 PLEC MBD2	1.72e-06	55	83	5	CID000032518
Drug	3-methylcholanthrene	CDSN CYP2C19 CYP2C9 APOB PLEC MBD2 ITIH4 TP53	2.04e-06	231	83	8	CID000001674
Drug	2-nitroanisole	CYP2C19 CYP2C9 XDH	3.86e-06	9	83	3	ctd:C005328
Drug	Diethylstilbestrol	BMP7 TRAF3 IGF1 FN1 ALMS1 INHA INPP5B NECTIN1 GAS6 LAMA4 XDH SMO ODF2 MBD2 ITIH4 TP53 SEZ6	3.89e-06	1305	83	17	ctd:D004054
Drug	Ibuprofen	ABHD4 SLC6A9 CDSN IGF1 CYP2C9 PCLO UBAC2 PLEC TP53 LACTB	4.27e-06	437	83	10	ctd:D007052
Drug	sitaxsentan	CYP2C19 CYP2C9 FN1	5.50e-06	10	83	3	ctd:C106276
Drug	Decamethonium bromide [541-22-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A	NF1 PTPRM INPP5B TMEM209 LAMA4 DGCR8 DHX34	7.03e-06	194	83	7	4174_DN
Drug	Betonicine [515-25-3]; Up 200; 25.2uM; MCF7; HT_HG-U133A	IGF1 PCLO NECTIN1 SCN8A C4BPA MBD2 HR	7.27e-06	195	83	7	6063_UP
Drug	Pargyline hydrochloride [306-07-0]; Up 200; 20.4uM; HL60; HG-U133A	BMP7 FN1 ALMS1 INHA PSG11 C4BPA DHX34	7.52e-06	196	83	7	1418_UP
Drug	phenindione	CYP2C9 F9 TP53	7.55e-06	11	83	3	CID000004760
Drug	genistein; Down 200; 10uM; PC3; HT_HG-U133A	ORC5 NF1 IPO8 FN1 INPP5B DHX34 SBNO2	7.77e-06	197	83	7	4459_DN
Drug	Fenofibrate [49562-28-9]; Up 200; 11uM; MCF7; HT_HG-U133A	SLC6A9 ORC5 NF1 IPO8 TBL1Y NECTIN1 XDH	7.77e-06	197	83	7	7474_UP
Drug	Iodixanol [92339-11-2]; Up 200; 2.6uM; HL60; HT_HG-U133A	BMP7 SCN8A LAMA4 C4BPA DGCR8 MBD2 DHX34	8.03e-06	198	83	7	3023_UP
Drug	BAS 012416453; Up 200; 38uM; PC3; HT_HG-U133A	IGF1 NF1 IPO8 FN1 SCN8A LAMA4 HR	8.30e-06	199	83	7	6876_UP
Drug	tungstopterin	NF1 RDH5 SMO APOB PLEC F9	8.49e-06	131	83	6	CID005460240
Drug	taxifolin	TRAF3 GAS6 XDH APOB	9.89e-06	37	83	4	ctd:C003377
Drug	3-demethylcolchicine	FLNB CYP2C19 CYP2C9	1.00e-05	12	83	3	CID000299664
Drug	Proteoglycans	BMP7 IGF1 XDH	1.30e-05	13	83	3	ctd:D011509
Drug	dibenzylfluorescein	CYP2C19 CYP2C9	1.31e-05	2	83	2	ctd:C558664
Drug	decamethrin	FLNB CYP2C19 CYP2C9 SCN8A XDH TP53	1.58e-05	146	83	6	ctd:C017180
Drug	5-MeO-DIPT	CYP2C19 CYP2C9 TCIRG1	1.65e-05	14	83	3	CID000151182
Drug	AC1L1IPV	PSG2 PSG3 SFTPD PSG11	1.82e-05	43	83	4	CID000004683
Drug	25(OH) vitamin D3	CDSN IGF1 NF1 CASR APOB ITIH4	1.84e-05	150	83	6	CID000001593
Drug	warf	CYP2C19 CYP2C9 XDH	2.06e-05	15	83	3	CID000031385
Drug	N-desethyloxybutynin	CYP2C19 CYP2C9 MBD2	2.06e-05	15	83	3	CID000133577
Drug	Amodiaquine	CYP2C19 CYP2C9 TP53	2.53e-05	16	83	3	ctd:D000655
Drug	androstan-3-ol	CYP2C9 NF1 INHA RDH5 SMO PLEC	2.65e-05	160	83	6	CID000092877
Drug	2cgu	CYP2C19 CYP2C9 FN1 TEC	2.83e-05	48	83	4	CID003506204
Drug	PB-3	CYP2C9 APOB PLEC MBD2	2.83e-05	48	83	4	CID005289109
Drug	3-[18-(2-carboxyethyl)-8-(1-hydroxy-5,9,13-trimethyl-tetradeca-4,8,12-trienyl)-3,7,12,17-tetramethyl-13-vinyl-1,2,3,6,7,8,9,12,17,18-decahydroporphine-21,22,23,24-tetraid-2-yl]propionic acid;iron(4+)	BMP7 TCIRG1 F9	3.66e-05	18	83	3	CID011984599
Drug	azalanstat	CYP2C9 APOB MBD2	3.66e-05	18	83	3	CID000060876
Drug	hydroxyapatite	BMP7 FN1 C4BPA TEC F9 TP53	3.85e-05	171	83	6	CID000014781
Drug	picoxystrobin	CYP2C19 CYP2C9	3.93e-05	3	83	2	ctd:C556557
Drug	mono-N-demethyladinazolam	CYP2C19 CYP2C9	3.93e-05	3	83	2	ctd:C050132
Drug	2-hydroxychlorpropamide	CYP2C19 CYP2C9	3.93e-05	3	83	2	CID003082454
Drug	MA-Ado	XDH MBD2	3.93e-05	3	83	2	CID003081401
Drug	Delavirdine	CYP2C19 CYP2C9	3.93e-05	3	83	2	ctd:D020008
Drug	L-NMMA	IGF1 CYP2C9 FN1 XDH TEC TP53	4.24e-05	174	83	6	CID000004366
Drug	pantoprazole	CYP2C19 CYP2C9 C4BPA	4.34e-05	19	83	3	ctd:C064276
Drug	olivacine	CYP2C19 CYP2C9 MBD2	5.09e-05	20	83	3	CID005281407
Drug	Quinidine	CYP2C19 IGF1 CYP2C9 TP53	5.22e-05	56	83	4	ctd:D011802
Drug	AC-474	FLNB CYP2C19 CYP2C9 APOB	6.41e-05	59	83	4	CID000002999
Drug	0175029-0000 [211245-78-2]; Down 200; 1uM; MCF7; HT_HG-U133A	ORC5 BMP7 TRAF3 ALMS1 DHX34 SBNO2	6.71e-05	189	83	6	4716_DN
Drug	quazepam	CYP2C19 CYP2C9 MBD2	6.84e-05	22	83	3	CID000004999
Drug	azoline	CYP2C19 CYP2C9 ITIH4	6.84e-05	22	83	3	CID003013050
Drug	Lansoprazole	CYP2C19 CYP2C9 C4BPA TP53	7.31e-05	61	83	4	ctd:D064747
Drug	Puromycin Aminonucleoside	BMP7 FN1 XDH CORIN APOB TP53	7.32e-05	192	83	6	ctd:D011692
Drug	NSC23615	FLNB IGF1 APOB APOBEC4 TP53 HR	7.54e-05	193	83	6	CID000000640
Drug	Dioxybenzone [131-53-3]; Up 200; 16.4uM; MCF7; HT_HG-U133A	NF1 INPP5B LAMA4 DGCR8 MBD2 F9	7.75e-05	194	83	6	5699_UP
Drug	Thioproperazine dimesylate [2347-80-0]; Up 200; 6.2uM; PC3; HT_HG-U133A	BMP7 PSG11 NECTIN1 DHX34 F9 SBNO2	7.75e-05	194	83	6	5791_UP
Drug	Skimmianine [83-95-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A	CYP2C9 NF1 SCN8A C4BPA MBD2 HR	7.75e-05	194	83	6	6066_UP
Drug	Atovaquone [95233-18-4]; Up 200; 11uM; MCF7; HT_HG-U133A	NF1 INHA CASR MBD2 DHX34 HR	7.75e-05	194	83	6	4786_UP
Drug	1-(6-((2-(dimethylamino)ethyl)(methyl)amino)-1,3-dimethyl-1H-pyrazolo(3,4-b)pyridine-5-carbonyl)-3-(3-isopropoxyphenyl)urea	CYP2C19 CYP2C9	7.84e-05	4	83	2	ctd:C558737
Drug	phthoxazolin A	IGF1 CORIN	7.84e-05	4	83	2	CID006439292
Drug	methysticin	CYP2C19 CYP2C9	7.84e-05	4	83	2	ctd:C076881
Drug	rabeprazole-thioether	CYP2C19 CYP2C9	7.84e-05	4	83	2	ctd:C523099
Drug	7,8-dihydromethysticin	CYP2C19 CYP2C9	7.84e-05	4	83	2	ctd:C107882
Drug	Phenelzine sulfate [156-51-4]; Down 200; 17uM; PC3; HT_HG-U133A	BMP7 INPP5B XDH SMO SBNO2 HR	7.98e-05	195	83	6	3802_DN
Drug	Gallamine triethiodide [65-29-2]; Up 200; 4.4uM; MCF7; HT_HG-U133A	NF1 INPP5B PCLO C4BPA ODF2 SBNO2	7.98e-05	195	83	6	6215_UP
Drug	Metolazone [17560-51-9]; Down 200; 11uM; MCF7; HT_HG-U133A	NF1 IPO8 ALMS1 MAPKBP1 DHX34 SBNO2	7.98e-05	195	83	6	1514_DN
Drug	Isradipine [75695-93-1]; Down 200; 10.8uM; MCF7; HT_HG-U133A	ORC5 FN1 ALMS1 INPP5B TMEM209 DGCR8	7.98e-05	195	83	6	5447_DN
Drug	Lactobionic acid [96-82-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A	ORC5 NF1 IPO8 FN1 MACO1 SPTLC1	7.98e-05	195	83	6	3246_UP
Drug	2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A	FN1 SFTPD NECTIN1 LAMA4 DGCR8 MBD2	7.98e-05	195	83	6	5582_UP
Drug	Boldine [476-70-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A	FN1 PTPRM MACO1 MBD2 SBNO2 HR	8.21e-05	196	83	6	4122_DN
Drug	Finasteride [98319-26-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A	TBL1Y NECTIN1 TMEM209 C4BPA DGCR8 HR	8.21e-05	196	83	6	6062_UP
Drug	SC-560; Up 200; 10uM; PC3; HT_HG-U133A	NF1 SPTLC1 TMEM209 LAMA4 ODF2 SBNO2	8.21e-05	196	83	6	6865_UP
Drug	Tremorine dihydrochloride [300-68-5]; Up 200; 15uM; MCF7; HT_HG-U133A	NF1 FN1 INPP5B XDH PLEC MBD2	8.21e-05	196	83	6	6273_UP
Drug	CAY10397; Down 200; 10uM; PC3; HT_HG-U133A	INPP5B SPTLC1 DGCR8 PLEC DHX34 SBNO2	8.21e-05	196	83	6	7087_DN
Drug	Xamoterol hemifumarate [73210-73-8]; Down 200; 5uM; HL60; HT_HG-U133A	ORC5 NF1 FN1 C4BPA PLEC MAPKBP1	8.44e-05	197	83	6	3064_DN
Drug	sulindac sulfone; Up 200; 50uM; MCF7; HG-U133A	SLC6A9 PSG11 LAMA4 RDH5 SMO SBNO2	8.44e-05	197	83	6	314_UP
Drug	Dicloxacillin sodium salt [13412-64-1]; Up 200; 8.2uM; PC3; HT_HG-U133A	CYP2C9 INHA TBL1Y SMO DHX34 TP53	8.44e-05	197	83	6	6666_UP
Drug	Sulfameter [651-06-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A	FN1 INPP5B GAS6 MAPKBP1 DHX34 HR	8.44e-05	197	83	6	3453_UP
Drug	Pridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A	ABHD4 BMP7 NF1 IPO8 INPP5B PLEC	8.44e-05	197	83	6	3456_DN
Drug	thioridazine hydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A	ORC5 NF1 PCLO NECTIN1 LAMA4 MBD2	8.68e-05	198	83	6	5916_DN
Drug	Idoxuridine [54-42-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A	ORC5 ALMS1 GAS6 PLEC ODF2 SBNO2	8.68e-05	198	83	6	4785_DN
Drug	Acenocoumarol [152-72-7]; Up 200; 11.4uM; MCF7; HT_HG-U133A	NF1 IPO8 INPP5B CAPRIN2 SCN8A DGCR8	8.68e-05	198	83	6	7232_UP
Drug	Prednisone [53-03-2]; Down 200; 11.2uM; HL60; HG-U133A	NF1 FN1 INPP5B XDH MAPKBP1 DHX34	8.68e-05	198	83	6	1978_DN
Drug	Pyrithyldione [77-04-3]; Up 200; 24uM; MCF7; HT_HG-U133A	ORC5 NF1 ALMS1 GAS6 TMEM209 CASR	8.68e-05	198	83	6	3482_UP
Drug	Benfotiamine [22457-89-2]; Up 200; 8.6uM; MCF7; HT_HG-U133A	IGF1 FN1 INHA PCLO C4BPA DGCR8	8.68e-05	198	83	6	3931_UP
Drug	Fenofibrate [49562-28-9]; Down 200; 11uM; MCF7; HT_HG-U133A	BMP7 TMEM209 DGCR8 PLEC MAPKBP1 ODF2	8.68e-05	198	83	6	7474_DN
Drug	Famotidine [76824-35-6]; Up 200; 11.8uM; HL60; HG-U133A	NF1 NECTIN2 SPTLC1 LAMA4 ODF2 HR	8.68e-05	198	83	6	2029_UP
Drug	Dehydrocholic acid [81-23-2]; Up 200; 9.6uM; MCF7; HT_HG-U133A	NF1 INPP5B NECTIN1 CAPRIN2 DHX34 HR	8.68e-05	198	83	6	1523_UP
Drug	Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; PC3; HT_HG-U133A	BMP7 NF1 INPP5B ERMP1 ODF2 DHX34	8.68e-05	198	83	6	3756_DN
Drug	Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A	BMP7 FN1 PTPRM PCLO MBD2 HR	8.68e-05	198	83	6	4133_DN
Drug	GSK-3 Inhibitor IX; Down 200; 0.5uM; MCF7; HT_HG-U133A	NF1 MACO1 SPTLC1 ERMP1 MAPKBP1 SBNO2	8.68e-05	198	83	6	6589_DN
Drug	PF-01378883-00 [351320-41-7]; Down 200; 10uM; PC3; HT_HG-U133A	ORC5 IPO8 FN1 TMEM209 LAMA4 DHX34	8.92e-05	199	83	6	6410_DN
Drug	rotenone; Down 200; 1uM; PC3; HT_HG-U133A	NF1 FN1 SCN8A DGCR8 PLEC SBNO2	8.92e-05	199	83	6	5920_DN
Drug	Condelphine [7633-69-4]; Up 200; 8.8uM; PC3; HT_HG-U133A	NF1 IPO8 TBL1Y INPP5B DHX34 SBNO2	8.92e-05	199	83	6	6357_UP
Drug	Ketorolac tromethamine [74103-07-4]; Down 200; 10.6uM; MCF7; HT_HG-U133A	TRAF3 INPP5B TMEM209 MAPKBP1 ODF2 HR	8.92e-05	199	83	6	5988_DN
Drug	Cefotaxime sodium salt [64485-93-4]; Up 200; 8.4uM; MCF7; HT_HG-U133A	CYP2C9 NF1 FN1 INHA TMEM209 DGCR8	8.92e-05	199	83	6	2235_UP
Drug	iron azide hydrate	TCIRG1 SMO TEC	8.95e-05	24	83	3	CID004475494
Drug	N-nitrosomethylethylamine	CYP2C19 CYP2C9 MBD2	8.95e-05	24	83	3	CID000025418
Drug	ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A	BMP7 PSG11 LAMA4 DGCR8 DHX34 TP53	9.17e-05	200	83	6	5969_UP
Drug	dibenzofurans	ALMS1 PLEC TEC MBD2	9.96e-05	66	83	4	CID000000568
Drug	Aconitine	CYP2C19 CYP2C9 TP53	1.01e-04	25	83	3	ctd:D000157
Disease	Herpes Simplex Infections	NECTIN1 NECTIN2	7.63e-06	2	82	2	C0019348
Disease	Acute kidney injury	CYP2C19 IGF1 CYP2C9 GAS6 TP53	9.41e-06	101	82	5	C2609414
Disease	Acute Kidney Insufficiency	CYP2C19 IGF1 CYP2C9 GAS6 TP53	9.41e-06	101	82	5	C1565662
Disease	Kidney Failure, Acute	CYP2C19 IGF1 CYP2C9 GAS6 TP53	9.41e-06	101	82	5	C0022660
Disease	B Virus Infection	NECTIN1 SCN8A	2.28e-05	3	82	2	C0037140
Disease	Herpesviridae Infections	NECTIN1 SCN8A	2.28e-05	3	82	2	C0019372
Disease	X-21258 measurement	CYP2C19 CYP2C9	2.28e-05	3	82	2	EFO_0800802
Disease	Dyslipidemias	MACO1 NECTIN2 APOB	4.01e-05	24	82	3	C0242339
Disease	Dyslipoproteinemias	MACO1 NECTIN2 APOB	4.01e-05	24	82	3	C0598784
Disease	Coumarin Resistance	CYP2C9 F9	4.56e-05	4	82	2	C0750384
Disease	tyrosine-protein kinase TEC measurement	TEC TEC	4.56e-05	4	82	2	EFO_0020830
Disease	calcium oxalate nephrolithiasis (is_implicated_in)	FN1 CASR	7.59e-05	5	82	2	DOID:0080652 (is_implicated_in)
Disease	Adenoma, Microcystic	IGF1 NF1 TP53	1.38e-04	36	82	3	C0205648
Disease	Adenoma, Monomorphic	IGF1 NF1 TP53	1.38e-04	36	82	3	C0205649
Disease	Adenoma, Basal Cell	IGF1 NF1 TP53	1.38e-04	36	82	3	C0205646
Disease	Follicular adenoma	IGF1 NF1 TP53	1.38e-04	36	82	3	C0205647
Disease	Papillary adenoma	IGF1 NF1 TP53	1.38e-04	36	82	3	C0205650
Disease	Adenoma, Trabecular	IGF1 NF1 TP53	1.38e-04	36	82	3	C0205651
Disease	Adenoma	IGF1 NF1 TP53	1.38e-04	36	82	3	C0001430
Disease	alopecia (is_implicated_in)	CDSN HR	1.59e-04	7	82	2	DOID:987 (is_implicated_in)
Disease	Brain Neoplasms	CYP2C9 SMO TP53	1.76e-04	39	82	3	C0006118
Disease	diabetes mellitus (is_marker_for)	IGF1 FN1 APOB	2.04e-04	41	82	3	DOID:9351 (is_marker_for)
Disease	X-11787 measurement	CYP2C9 ALMS1	2.11e-04	8	82	2	EFO_0021258
Disease	basal cell carcinoma (is_marker_for)	SMO TP53	2.11e-04	8	82	2	DOID:2513 (is_marker_for)
Disease	Clinically Isolated Syndrome, CNS Demyelinating	IGF1 TP53	2.11e-04	8	82	2	C2350037
Disease	Demyelinating Diseases	IGF1 TP53	2.11e-04	8	82	2	C0011303
Disease	Demyelination	IGF1 TP53	2.11e-04	8	82	2	C0011304
Disease	Early Pregnancy Loss	IGF1 FN1 INHA LAMA4	2.47e-04	109	82	4	C3830362
Disease	Spontaneous abortion	IGF1 FN1 INHA LAMA4	2.47e-04	109	82	4	C0000786
Disease	Miscarriage	IGF1 FN1 INHA LAMA4	2.47e-04	109	82	4	C4552766
Disease	Abortion, Tubal	IGF1 FN1 INHA LAMA4	2.47e-04	109	82	4	C0000822
Disease	Thrombus	CYP2C19 GAS6 F9	2.88e-04	46	82	3	C0087086
Disease	Thrombosis	CYP2C19 GAS6 F9	3.48e-04	49	82	3	C0040053
Disease	low density lipoprotein cholesterol measurement, phospholipid measurement	MACO1 NECTIN2 GAS6 APOB	3.56e-04	120	82	4	EFO_0004611, EFO_0004639
Disease	X-11308 measurement	CYP2C19 CYP2C9	4.13e-04	11	82	2	EFO_0800693
Disease	total lipids in medium VLDL	GAS6 APOB ITIH4	4.63e-04	54	82	3	EFO_0022153
Disease	basal cell carcinoma (is_implicated_in)	SMO TP53	4.94e-04	12	82	2	DOID:2513 (is_implicated_in)
Disease	thymol sulfate measurement	CYP2C19 CYP2C9	4.94e-04	12	82	2	EFO_0021170
Disease	cleft palate (is_implicated_in)	FLNB NECTIN1	4.94e-04	12	82	2	DOID:674 (is_implicated_in)
Disease	Abnormality of the dentition	BMP7 SPTLC1	4.94e-04	12	82	2	HP_0000164
Disease	ceramide measurement	SPTLC1 CORIN APOB TEC TEC	5.09e-04	235	82	5	EFO_0010222
Disease	apolipoprotein B measurement	NF1 FN1 MACO1 NECTIN2 GAS6 APOB PLEC TP53	5.15e-04	663	82	8	EFO_0004615
Disease	Major Depressive Disorder	BMP7 CYP2C19 CYP2C9 PCLO XDH	5.92e-04	243	82	5	C1269683
Disease	Malignant neoplasm of skin	IGF1 SMO TP53	6.01e-04	59	82	3	C0007114
Disease	Skin Neoplasms	IGF1 SMO TP53	6.01e-04	59	82	3	C0037286
Disease	free cholesterol in VLDL measurement	NECTIN2 GAS6 APOB	6.63e-04	61	82	3	EFO_0022276
Disease	Sarcoma, Spindle Cell	NF1 TP53	6.79e-04	14	82	2	C0205945
Disease	Sarcoma, Epithelioid	NF1 TP53	6.79e-04	14	82	2	C0205944
Disease	vascular dementia (biomarker_via_orthology)	IGF1 TP53	6.79e-04	14	82	2	DOID:8725 (biomarker_via_orthology)
Disease	hemorrhoid	NF1 PLEC TP53 PHLDB2	7.65e-04	147	82	4	EFO_0009552
Disease	Malignant neoplasm of breast	FLNB IGF1 LLGL2 NF1 FN1 NECTIN2 SPTLC1 OSBPL11 XDH TP53	7.79e-04	1074	82	10	C0006142
Disease	non-high density lipoprotein cholesterol measurement	FN1 PSG3 MACO1 GAS6 OSBPL9 APOB TP53 LACTB	8.27e-04	713	82	8	EFO_0005689
Disease	low density lipoprotein cholesterol measurement, physical activity	MACO1 NECTIN2 APOB	8.34e-04	66	82	3	EFO_0003940, EFO_0004611
Disease	sickle cell anemia (is_implicated_in)	CYP2C19 APOB	8.93e-04	16	82	2	DOID:10923 (is_implicated_in)
Disease	Pontoneocerebellar hypoplasia	PCLO CLP1	8.93e-04	16	82	2	cv:C1261175
Disease	pre-malignant neoplasm (biomarker_via_orthology)	SMO TP53	1.01e-03	17	82	2	DOID:0060071 (biomarker_via_orthology)
Disease	level of Sphingomyelin (d32:1) in blood serum	ERMP1 KCNH5	1.01e-03	17	82	2	OBA_2045173
Disease	sphingomyelin measurement	NECTIN2 SCN8A SPTLC1 CASR APOB	1.08e-03	278	82	5	EFO_0010118
Disease	asthma	CDSN TRAF3 TM9SF2 UBAC2 CASR ERMP1 DNAAF9 SBNO2	1.15e-03	751	82	8	MONDO_0004979
Disease	cystathionine measurement	TEC TEC	1.27e-03	19	82	2	EFO_0010474
Disease	Pheochromocytoma	NF1 TP53	1.27e-03	19	82	2	C0031511
Disease	monounsaturated fatty acids; 16:1, 18:1 measurement	NECTIN2 GAS6 APOB	1.35e-03	78	82	3	EFO_0022187
Disease	Sarcoma	NF1 TP53	1.55e-03	21	82	2	C1261473
Disease	pulse pressure measurement	FLNB CDSN CYP2C9 FN1 INPP5B ODF2 TEC DHX34 TEC TP53 LACTB	1.60e-03	1392	82	11	EFO_0005763
Disease	Alveolitis, Fibrosing	BMP7 IGF1 FN1	1.62e-03	83	82	3	C4721507
Disease	Giant Cell Glioblastoma	NF1 FN1 TP53	1.68e-03	84	82	3	C0334588
Disease	colorectal carcinoma (is_implicated_in)	STRAP TP53	1.70e-03	22	82	2	DOID:0080199 (is_implicated_in)
Disease	systemic lupus erythematosus	TRAF3 TM9SF2 INPP5B UBAC2 CASR SMO APOBEC4 SBNO2	1.70e-03	799	82	8	MONDO_0007915
Disease	Pulmonary Fibrosis	BMP7 IGF1 FN1	1.73e-03	85	82	3	C0034069
Disease	free cholesterol measurement, high density lipoprotein cholesterol measurement	CYP2C19 MACO1 NECTIN2 APOB MAPKBP1	1.87e-03	315	82	5	EFO_0004612, EFO_0008591
Disease	HMG CoA reductase inhibitor use measurement	NECTIN2 GAS6 APOB PLEC	1.93e-03	189	82	4	EFO_0009932
Disease	Coronary heart disease	MACO1 APOB	2.02e-03	24	82	2	C0010068
Disease	airway responsiveness measurement	IPO8 CAPRIN2	2.02e-03	24	82	2	EFO_0006897
Disease	Behcet Syndrome	UBAC2 APOB	2.02e-03	24	82	2	C0004943
Disease	sleep duration, low density lipoprotein cholesterol measurement	MACO1 NECTIN2 APOB	2.11e-03	91	82	3	EFO_0004611, EFO_0005271
Disease	age of onset of childhood onset asthma	TRAF3 UBAC2 SBNO2	2.17e-03	92	82	3	OBA_2001015
Disease	Alzheimer disease, high density lipoprotein cholesterol measurement	NECTIN2 APOB	2.37e-03	26	82	2	EFO_0004612, MONDO_0004975
Disease	lymphocyte count	FLNB TRAF3 CYP2C19 CYP2C9 TM9SF2 FN1 ALMS1 NECTIN2 GAS6 PLEC SBNO2	2.38e-03	1464	82	11	EFO_0004587
Disease	low density lipoprotein cholesterol measurement, alcohol consumption measurement	MACO1 GAS6 APOB	2.68e-03	99	82	3	EFO_0004611, EFO_0007878
Disease	eosinophil count	BMP7 TRAF3 TM9SF2 NECTIN2 UBAC2 CASR ERMP1 PLEC ITIH4 TP53 SBNO2	2.69e-03	1488	82	11	EFO_0004842
Disease	Subfertility, Female	SMO TP53	2.75e-03	28	82	2	C0341869
Disease	Sterility, Postpartum	SMO TP53	2.75e-03	28	82	2	C0038279
Disease	Pigmented Basal Cell Carcinoma	SMO TP53	2.75e-03	28	82	2	C1368275
Disease	Ischemia	XDH TP53	2.75e-03	28	82	2	C0022116
Disease	Female sterility	SMO TP53	2.75e-03	28	82	2	C0917730
Disease	Female infertility	SMO TP53	2.75e-03	28	82	2	C0021361

Protein segments in the cluster

Peptide	Gene	Start	Entry
SGFGPIYNYKDTIVF	C4BPA	251	P04003
YGTTFPQTKHLTFYE	APOBEC4	56	Q8WW27
FIPAYASTYGKFVSA	CASR	821	P41180
GKFTCSIPGIYFFTY	C1QL3	161	Q5VWW1
STFYSHTEKPGVFYQ	ALMS1	1331	Q8TCU4
SLGGFLATSYSIKYP	ABHD4	146	Q8TB40
FKPGTGYSQVSYSSG	CDSN	106	Q15517
PFNFYGASLLSKGSF	DGCR8	66	Q8WYQ5
QGFSYPYKAVFSTQG	BMP7	101	P18075
TPVTSKGGDYFVFYS	ERMP1	821	Q7Z2K6
PLVTSFTGKYGSIQY	ARRDC4	126	Q8NCT1
GSTFFKYYLQGAKIP	ITIH4	621	Q14624
GYPFGYLKASTTLTC	INTS6L	366	Q5JSJ4
AGSFTSSLAQPGAYY	IRX6	111	P78412
YSANIIFHTKPFYGG	OSBPL9	586	Q96SU4
SFGAPYGTTTLKYFQ	FAM166C	36	A6NJV1
FYIKAYTPRGASSAS	IGDCC3	496	Q8IVU1
CVFTKYGQGFYLISP	LLGL2	901	Q6P1M3
KPGSQFLYSTFGYTL	LACTB	316	P83111
GGPSKDSLYVSSLYF	KCNH5	411	Q8NCM2
PSAFSLGSKGFYYKD	HR	196	O43593
YPVVTLGFGFKSYVS	MACO1	161	Q8N5G2
ANKPTYFDIYTAGAG	FLNB	371	O75369
PFQYTEGYTTKGSQT	PCLO	3696	Q9Y6V0
YTNIFLKFGSGYVSG	F9	341	P00740
SVPSQKTYQGSYGFR	TP53	96	P04637
YVGTFPDGQKFDSSY	FKBP9	61	O95302
SAGKSDVYYFSPSGK	MBD2	171	Q9UBB5
TAFVYTKNPNGYSFS	APOB	3706	P04114
NLSKIYGPVFTLYFG	CYP2C19	56	P33261
STPSFSSYYKGGFEQ	DNAJC15	76	Q9Y5T4
GLSPGVTYYFKVFAV	FN1	966	P02751
INKYGSPYTKNSGFA	GAS6	96	Q14393
SRTYFFGATHVPYLG	DNAAF9	341	Q5TEA3
FSKVLGPGVYSNVSY	CORIN	1011	Q9Y5Q5
IKESPYSPGYNQSFT	CAPRIN2	781	Q6IMN6
AFSPSAKYIVSVGYQ	MAPKBP1	141	O60336
YFLSVSGNYLPSCFG	INPP5B	771	P32019
GGYSFKYETVPNLLT	INHA	346	P05111
FYFNKPTGYGSSSRR	IGF1	71	P05019
NLSKVYGPVFTLYFG	CYP2C9	56	P11712
PTKGGYAVTDFLTYN	DHX34	1036	Q14147
FGGLLKYPESISYFS	PRDM13	486	Q9H4Q3
TLFLFGVTKYTAGPY	PSG11	201	Q9UQ72
LGSNSTYLYVGFPSE	KIF28P	471	B7ZC32
THFLFFGLYPGTTYS	PTPRM	546	P28827
YSASITFHTKPFYGG	OSBPL11	596	Q9BXB4
TLFLFGVTKYTAGPY	PSG3	201	Q16557
KKFYFGGSPISAQYA	LAMA4	1351	Q16363
KSSYANVFGDGPYST	ODF2	801	Q5BJF6
YGSPGNVTKEYFEFS	IPO8	276	O15397
AYLYKQGFAIPGSSF	TMEM41A	76	Q96HV5
SQPGLYTVSLYTKFG	TEC	276	P42680
PSIFIYGHTASGKTY	ORC5	31	O43913
KSLALTGPYDGFYLS	SBNO2	1056	Q9Y2G9
YLNFSSLSSGALPYK	PHLDB2	301	Q86SQ0
PATQAHYGGAFLTKY	RDH5	231	Q92781
YGFATIASAIPAYSK	SPTLC1	166	O15269
AFSGITPYGYFLISA	STRAP	21	Q9Y3F4
VSFNYYGVVTGPSAS	BROX	16	Q5VW32
YHFGSTTPGTNIKLY	CLP1	186	Q92989
YFSTLQPGKASLAYF	TXNDC16	36	Q9P2K2
KTLSLYSQPFYTGYF	TRAF3	436	Q13114
VPASLTTKYGGFYIN	UBN2	226	Q6ZU65
EGKFTYPTGESLVYS	SFTPD	321	P35247
AGTSKAGNPIFYYVA	NF1	1596	P21359
SSGKVVYFTATFPYV	SLC6A9	311	P48067
KAGRNPNYGYTSFDT	SCN8A	341	Q9UQD0
FVKYGNFSSSTPTYP	SEZ6	536	Q53EL9
TGFYRTPNLGYSFET	XDH	1131	P47989
QSTKGYYSPYSVSGS	PLEC	4606	Q15149
YSVAFSPDGKYLASG	TBL1Y	456	Q9BQ87
LGTTYQPLSGKTSYF	SMO	346	Q99835
VTYSPVSGYNKLASF	TMEM209	181	Q96SK2
GTPAGYVAARFYKSF	TM9SF2	411	Q99805
PIGLYFTTKSYIFEG	VMA21	41	Q3ZAQ7
TLFLFGVTKYTAGPY	PSG2	201	P11465
YGTGETFLFSFSPQL	TLDC2	131	A0PJX2
YFFGITAASNLPSGF	UBAC2	116	Q8NBM4
VFQSLPKSAFSGGYY	DNAJC19	36	Q96DA6
KFYSGTGYKLSPFTF	TCIRG1	811	Q13488
SRFGKYIDIYFNPSG	MYO7B	211	Q6PIF6
FFKGPINYSLAGTYI	NECTIN1	301	Q15223
LSYSSPSDSYQGKGF	NECTIN2	516	Q92692